

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Novel biomarkers and endoscopic techniques for... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1643/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1643" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy" />
    
            <meta name="og:title" content="F1000Research Article: Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy.">
            <meta name="og:description" content="Read the latest article version by Margaret G Keane, Amar Shah, Stephen P Pereira, Deepak Joshi, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12275">
            <meta name="article-id" content="11371">
            <meta name="dc.title" content="Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy">
            <meta name="dc.description" content="The UK incidence of pancreatic ductal adenocarcinoma is 9 per 100,000 population, and biliary tract cancer occurs at a rate of 1&ndash;2 per 100,000. The incidence of both cancers is increasing annually and these tumours continue to be diagnosed late and at an advanced stage, limiting options for curative treatment. Population-based screening programmes do not exist for these cancers, and diagnosis currently is dependent on symptom recognition, but often symptoms are not present until the disease is advanced. Recently, a number of promising blood and urine biomarkers have been described for pancreaticobiliary malignancy and are summarised in this review. Novel endoscopic techniques such as single-operator cholangioscopy and confocal endomicroscopy have been used in some centres to enhance standard endoscopic diagnostic techniques and are also evaluated in this review.">
            <meta name="dc.subject" content="Pancreaticobiliary malignancy, Endoscopic retrograde, cholangiopancreatography, CA 19-9, pancreatic, biliary">
            <meta name="dc.creator" content="Keane, Margaret G">
            <meta name="dc.creator" content="Shah, Amar">
            <meta name="dc.creator" content="Pereira, Stephen P">
            <meta name="dc.creator" content="Joshi, Deepak">
            <meta name="dc.date" content="2017/09/05">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11371.1">
            <meta name="dc.source" content="F1000Research 2017 6:1643">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Pancreaticobiliary malignancy">
            <meta name="prism.keyword" content="Endoscopic retrograde">
            <meta name="prism.keyword" content="cholangiopancreatography">
            <meta name="prism.keyword" content="CA 19-9">
            <meta name="prism.keyword" content="pancreatic">
            <meta name="prism.keyword" content="biliary">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/09/05">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1643">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11371.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1643">
            <meta name="citation_title" content="Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy">
            <meta name="citation_abstract" content="The UK incidence of pancreatic ductal adenocarcinoma is 9 per 100,000 population, and biliary tract cancer occurs at a rate of 1&ndash;2 per 100,000. The incidence of both cancers is increasing annually and these tumours continue to be diagnosed late and at an advanced stage, limiting options for curative treatment. Population-based screening programmes do not exist for these cancers, and diagnosis currently is dependent on symptom recognition, but often symptoms are not present until the disease is advanced. Recently, a number of promising blood and urine biomarkers have been described for pancreaticobiliary malignancy and are summarised in this review. Novel endoscopic techniques such as single-operator cholangioscopy and confocal endomicroscopy have been used in some centres to enhance standard endoscopic diagnostic techniques and are also evaluated in this review.">
            <meta name="citation_description" content="The UK incidence of pancreatic ductal adenocarcinoma is 9 per 100,000 population, and biliary tract cancer occurs at a rate of 1&ndash;2 per 100,000. The incidence of both cancers is increasing annually and these tumours continue to be diagnosed late and at an advanced stage, limiting options for curative treatment. Population-based screening programmes do not exist for these cancers, and diagnosis currently is dependent on symptom recognition, but often symptoms are not present until the disease is advanced. Recently, a number of promising blood and urine biomarkers have been described for pancreaticobiliary malignancy and are summarised in this review. Novel endoscopic techniques such as single-operator cholangioscopy and confocal endomicroscopy have been used in some centres to enhance standard endoscopic diagnostic techniques and are also evaluated in this review.">
            <meta name="citation_keywords" content="Pancreaticobiliary malignancy, Endoscopic retrograde, cholangiopancreatography, CA 19-9, pancreatic, biliary">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Margaret G Keane">
            <meta name="citation_author_institution" content="Institute of Liver Studies, King's College Hospital, London, UK">
            <meta name="citation_author" content="Amar Shah">
            <meta name="citation_author_institution" content="Institute of Liver Studies, King's College Hospital, London, UK">
            <meta name="citation_author" content="Stephen P Pereira">
            <meta name="citation_author_institution" content="UCL Institute for Liver and Digestive Health, Royal Free Campus, London, UK">
            <meta name="citation_author" content="Deepak Joshi">
            <meta name="citation_author_institution" content="Institute of Liver Studies, King's College Hospital, London, UK">
            <meta name="citation_publication_date" content="2017/09/05">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1643">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11371.1">
            <meta name="citation_firstpage" content="1643">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1643/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1643.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12275 /> <input type=hidden id=articleId name=articleId value=11371 /> <input type=hidden id=xmlUrl value="/articles/6-1643/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1643-v1.xml"> <input type=hidden id=article_uuid value=082c9d35-7976-4f33-8cea-4059ddc78cd8 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11371.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11371.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1643"
  },
  "headline": "Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy",
  "datePublished": "2017-09-05T14:20:21",
  "dateModified": "2017-09-05T14:20:21",
  "author": [
    {
      "@type": "Person",
      "name": "Margaret G Keane"
    },    {
      "@type": "Person",
      "name": "Amar Shah"
    },    {
      "@type": "Person",
      "name": "Stephen P Pereira"
    },    {
      "@type": "Person",
      "name": "Deepak Joshi"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "The UK incidence of pancreatic ductal adenocarcinoma is 9 per 100,000 population, and biliary tract cancer occurs at a rate of 1&ndash;2 per 100,000. The incidence of both cancers is increasing annually and these tumours continue to be diagnosed late and at an advanced stage, limiting options for curative treatment. Population-based screening programmes do not exist for these cancers, and diagnosis currently is dependent on symptom recognition, but often symptoms are not present until the disease is advanced. Recently, a number of promising blood and urine biomarkers have been described for pancreaticobiliary malignancy and are summarised in this review. Novel endoscopic techniques such as single-operator cholangioscopy and confocal endomicroscopy have been used in some centres to enhance standard endoscopic diagnostic techniques and are also evaluated in this review."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1643/v1",
            "name": "Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary..."
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary... </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12275 data-id=11371 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11371.1" data-recommended="" data-doi="10.12688/f1000research.11371.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1643/v1/pdf?article_uuid=082c9d35-7976-4f33-8cea-4059ddc78cd8" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11371-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11371-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11371-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Keane MG, Shah A, Pereira SP and Joshi D. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1643 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11371.1" target=_blank>https://doi.org/10.12688/f1000research.11371.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11371-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11371 id=track-article-signin-11371 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11371?target=/articles/6-1643/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12275 /> <input name=articleId type=hidden value=11371 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Margaret G Keane<a href="https://orcid.org/0000-0001-7477-4541" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7477-4541</div><sup>1</sup>,&nbsp;</span><span class="">Amar Shah<sup>1</sup>,&nbsp;</span><span class="">Stephen P Pereira<a href="https://orcid.org/0000-0003-0821-1809" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0821-1809</div><sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:d.joshi@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Deepak Joshi</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Margaret G Keane<a href="http://orcid.org/0000-0001-7477-4541" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-7477-4541</div><sup>1</sup>,&nbsp;</span><span class="">Amar Shah<sup>1</sup>,&nbsp;</span><span class="">Stephen P Pereira<a href="http://orcid.org/0000-0003-0821-1809" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-0821-1809</div><sup>2</sup>,&nbsp;</span><span class=""><a href="mailto:d.joshi@nhs.net" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Deepak Joshi</span></a><sup>1</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 05 Sep 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11371.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Liver Studies, King's College Hospital, London, UK<br/> <sup>2</sup> UCL Institute for Liver and Digestive Health, Royal Free Campus, London, UK<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25505-25396></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25506-25395></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> The UK incidence of pancreatic ductal adenocarcinoma is 9 per 100,000 population, and biliary tract cancer occurs at a rate of 1–2 per 100,000. The incidence of both cancers is increasing annually and these tumours continue to be diagnosed late and at an advanced stage, limiting options for curative treatment. Population-based screening programmes do not exist for these cancers, and diagnosis currently is dependent on symptom recognition, but often symptoms are not present until the disease is advanced. Recently, a number of promising blood and urine biomarkers have been described for pancreaticobiliary malignancy and are summarised in this review. Novel endoscopic techniques such as single-operator cholangioscopy and confocal endomicroscopy have been used in some centres to enhance standard endoscopic diagnostic techniques and are also evaluated in this review. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Pancreaticobiliary malignancy, Endoscopic retrograde, cholangiopancreatography, CA 19-9, pancreatic, biliary </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Deepak Joshi (<a href="mailto:d.joshi@nhs.net">d.joshi@nhs.net</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Deepak Joshi </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> SPP is supported in part by National Institutes of Health grant P01CA8420. Part of the work was undertaken at University College London Hospitals/University College London, which received a portion of funding from the Department of Health’s National Institute for Health Research Biomedical Research Centres funding scheme. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Keane MG <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Keane MG, Shah A, Pereira SP and Joshi D. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1643 (<a href="https://doi.org/10.12688/f1000research.11371.1" target=_blank>https://doi.org/10.12688/f1000research.11371.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 05 Sep 2017, <b>6</b>(F1000 Faculty Rev):1643 (<a href="https://doi.org/10.12688/f1000research.11371.1" target=_blank>https://doi.org/10.12688/f1000research.11371.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 05 Sep 2017, <b>6</b>(F1000 Faculty Rev):1643 (<a href="https://doi.org/10.12688/f1000research.11371.1" target=_blank>https://doi.org/10.12688/f1000research.11371.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e195>Introduction</h2><p class="" id=d68666e198>In the UK, pancreatic ductal adenocarcinoma (PDAC) is the 10<sup>th</sup> commonest cancer and has an incidence of 9 per 100,000 population<sup><a href="#ref-1">1</a></sup>, and biliary tract cancer (BTC) (including intra- and extra-hepatic cholangiocarcinoma and gallbladder cancer) has an incidence of 1–2 cases per 100,000 population<sup><a href="#ref-2">2</a></sup>. Long-term survival is poor; 5-year survival is less than 4% for both tumours<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a></sup>. Often these tumours are diagnosed late, when patients have advanced disease and curative surgical resection is no longer possible.</p><p class="" id=d68666e219>Globally the highest incidence of PDAC is seen in Northern Europe and North America<sup><a href="#ref-5">5</a></sup>, where the rates are 3 to 4 times higher than in tropical countries<sup><a href="#ref-6">6</a></sup>. Overall incidence is increasing<sup><a href="#ref-5">5</a></sup>, and as most tumours are sporadic, this rising incidence is attributed to differences in lifestyles and exposure to environmental risk factors<sup><a href="#ref-7">7</a></sup>, such as smoking<sup><a href="#ref-8">8</a>–<a href="#ref-15">15</a></sup>, diabetes mellitus, chronic pancreatitis<sup><a href="#ref-1">1</a>,<a href="#ref-15">15</a>,<a href="#ref-16">16</a></sup> and obesity<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d68666e260>In BTC, the variations in incidence seen globally are even more pronounced; and the highest incidence is in northeastern Thailand (96 per 100,000 men)<sup><a href="#ref-18">18</a></sup>, which has a population with high levels of chronic typhoid and infestation of liver fluke (<i>Clonorchis sinensis</i> and <i>Opisthorchis viverinni</i>)<sup><a href="#ref-18">18</a></sup>. Other BTC risk factors seen in all populations include older age<sup><a href="#ref-18">18</a></sup>, primary sclerosing cholangitis<sup><a href="#ref-19">19</a></sup>, intraductal stones and rare biliary cystic diseases<sup><a href="#ref-20">20</a></sup>. Inflammatory bowel disease, chronic viral hepatitis, cirrhosis, smoking, diabetes, obesity and excess alcohol consumption may also increase the risk of BTC<sup><a href="#ref-20">20</a>–<a href="#ref-22">22</a></sup>.</p><p class="" id=d68666e297>Despite improved diagnostic techniques, detecting pancreaticobiliary malignancy remains a significant clinical challenge. A common presentation of these tumours is a biliary stricture with or without a mass lesion. The differential of an indeterminate biliary stricture is broad, and often the associated symptoms and radiological findings overlap between benign and malignant conditions, often making differentiation—particularly between cancer, primary sclerosing cholangitis and IgG4-related disease—impossible without further investigations, typically by endoscopic retrograde cholangiopancreatography (ERCP) or endoscopic ultrasound (EUS)<sup><a href="#ref-23">23</a>–<a href="#ref-25">25</a></sup>. However, biliary brush cytology is also an imperfect test, although specificity is high (96–100%), sensitivity for malignancy remains low (9–57%) and in early disease when tumours are small, sensitivities are even lower<sup><a href="#ref-26">26</a>,<a href="#ref-27">27</a></sup>. Therefore, patients frequently require multiple procedures to obtain a final diagnosis<sup><a href="#ref-28">28</a>–<a href="#ref-30">30</a></sup>.</p><p class="" id=d68666e322>So there has been growing interest in the development of simple tests to streamline the diagnosis to pancreaticobiliary malignancy and guide appropriate and timely therapy for patients. Identifying better diagnostic tools for PDAC and BTC would also make screening and surveillance possible, particularly in high-risk populations<sup><a href="#ref-4">4</a>,<a href="#ref-8">8</a>,<a href="#ref-31">31</a></sup>. This would enable the detection of tumours at an earlier stage when curative resection is possible, leading to substantial improvements in survival<sup><a href="#ref-32">32</a></sup>. This review provides an overview of the latest innovations in diagnostic biomarkers and endoscopic techniques for pancreaticobiliary malignancy.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e342>Methods</h2><p class="" id=d68666e345>We performed a systematic review of the literature by using PubMed, EMBASE and the Cochrane Library. The search was limited to studies published in the English language between January 2013 and March 2017. Medical Subject Headings (MeSH) terms were decided by a consensus of the authors and included “pancreatic cancer” or “cholangiocarcinoma” and “biomarker”. The search was restricted to title, abstract and keywords. Articles that described outcomes for fewer than five patients were excluded. Case reports, abstracts and reviews were excluded. All references were screened for potentially relevant studies not identified in the initial literature search.</p><p class="" id=d68666e348>The following variables were extracted for each report when available: number of malignant and benign cases, sensitivity, specificity and area under the curve (AUC). One hundred ten articles were included in the final review.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e354>Biomarkers</h2><div class=section><a name=d68666e357 class=n-a></a><h3 class=section-title>1. Serum biomarkers and blood tests</h3><p class="" id=d68666e362>Carbohydrate antigen (CA) 19-9 is the most widely used tumour marker in pancreaticobiliary malignancy. Overall sensitivity (78–89%) and specificity (67–87%) are low, and in around 7% of the population who lack the Lewis (a) antigen, CA19-9 will remain negative<sup><a href="#ref-33">33</a></sup>. In small tumours, sensitivity decreases further. The marker can also be elevated in a number of other malignant diseases (for example, gastric adenocarcinoma) and benign diseases, particularly those causing jaundice (for example, primary biliary cirrhosis, cholestasis and cholangitis), and in smokers<sup><a href="#ref-34">34</a></sup>. In addition, variation has been reported among commercially available assays, which may impact on interpretation<sup><a href="#ref-35">35</a></sup>. Therefore, to improve the sensitivity of the marker in current clinical practice, it is always interpreted in the context of cross-sectional imaging findings<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d68666e381>Other commercially available tumour markers that have a role in diagnosing pancreaticobiliary cancer include carcinoembryonic antigen (CEA) and CA125. CEA is a glycosyl phosphatidyl inositol cell surface-anchored glycoprotein that is involved in cell adhesion. When elevated, it is highly suggestive of colorectal cancer, but it is also increased in about a third of patients with BTC<sup><a href="#ref-36">36</a>–<a href="#ref-38">38</a></sup>. CA125 is a protein encoded by the <i>MUC16</i> gene and is a large membrane-associated glycoprotein with a single transmembrane domain. When elevated, it is suggestive of ovarian cancer, but it is also increased in about 40–50% of patients with pancreaticobiliary malignancy, particularly when there is peritoneal involvement<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d68666e398>Owing to the limitations of existing biomarkers, over the last few years several studies have evaluated various combinations of biomarkers to supplement or ultimately replace existing biomarkers. Biomarker panels using combinations of markers, often including CA19-9, have been particularly successful in detecting small tumours and early disease. Validation studies have also shown that these markers can differentiate PDAC from relevant benign conditions and in some cases detect tumours up to 1 year prior to diagnosis with a specificity of 95% and a sensitivity of 68%<sup><a href="#ref-7">7</a></sup> (<a href="#T1">Table 1</a> and <a href="#T2">Table 2</a>).</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Serum protein biomarkers for biliary tract cancer, 2013–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e422 class=n-a></a><thead><a name=d68666e424 class=n-a></a><tr><a name=d68666e426 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e428 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e431 class=n-a></a>Biomarker/<br class=br>Combination<br class=br>(serum)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e438 class=n-a></a>Biliary tract<br class=br>cancer, number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e443 class=n-a></a>Benign lesion/<br class=br>cholangitis,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e450 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e458 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e461 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e464 class=n-a></a>Area<br class=br>under the<br class=br>curve</th></tr></thead><tbody><a name=d68666e472 class=n-a></a><tr><a name=d68666e474 class=n-a></a><td align=left colspan=8 rowspan=1 valign=top><a name=d68666e476 class=n-a></a>Single biomarkers</td></tr><tr><a name=d68666e479 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e480 class=n-a></a>Han <i>et al</i>. (2013)<sup><a href="#ref-84">84</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e489 class=n-a></a>HDGF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e492 class=n-a></a>83</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e495 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e498 class=n-a></a>51</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e501 class=n-a></a>66%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e505 class=n-a></a>88%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e508 class=n-a></a>0.81</td></tr><tr><a name=d68666e511 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e512 class=n-a></a>Ruzzenente <i>et al</i>. (2014)<sup><a href="#ref-85">85</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e521 class=n-a></a>MUC5AC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e524 class=n-a></a>49</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e527 class=n-a></a>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e530 class=n-a></a>16</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e533 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e537 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e540 class=n-a></a>0.91</td></tr><tr><a name=d68666e543 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e544 class=n-a></a>Voigtlander <i>et al</i>. (2014)<sup><a href="#ref-86">86</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e553 class=n-a></a>Angpt-2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e556 class=n-a></a>56</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e559 class=n-a></a>111</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e562 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e565 class=n-a></a>74%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e569 class=n-a></a>94%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e572 class=n-a></a>0.85</td></tr><tr><a name=d68666e575 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e576 class=n-a></a>Lumachi <i>et al</i>. (2014)<sup><a href="#ref-87">87</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e585 class=n-a></a>CA 19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e588 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e591 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e594 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e597 class=n-a></a>74%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e601 class=n-a></a>82%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e604 class=n-a></a>-</td></tr><tr><a name=d68666e608 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e609 class=n-a></a>Wang <i>et al</i>. (2014)<sup><a href="#ref-88">88</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e618 class=n-a></a>CA 19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e621 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e624 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e627 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e630 class=n-a></a>72%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e634 class=n-a></a>96%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e637 class=n-a></a>-</td></tr><tr><a name=d68666e640 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e641 class=n-a></a>Lumachi <i>et al</i>. (2014)<sup><a href="#ref-87">87</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e650 class=n-a></a>CEA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e653 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e656 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e659 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e662 class=n-a></a>52%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e666 class=n-a></a>55%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e669 class=n-a></a>-</td></tr><tr><a name=d68666e672 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e673 class=n-a></a>Wang <i>et al</i>. (2014)<sup><a href="#ref-88">88</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e682 class=n-a></a>CEA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e685 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e688 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e691 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e694 class=n-a></a>11%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e698 class=n-a></a>97%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e701 class=n-a></a>-</td></tr><tr><a name=d68666e704 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e705 class=n-a></a>Wang <i>et al</i>. (2014)<sup><a href="#ref-88">88</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e714 class=n-a></a>CA 125</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e717 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e720 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e723 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e726 class=n-a></a>45%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e730 class=n-a></a>96%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e733 class=n-a></a>-</td></tr><tr><a name=d68666e736 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e737 class=n-a></a>Lumachi <i>et al</i>. (2014)<sup><a href="#ref-87">87</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e746 class=n-a></a>CYFRA 21-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e749 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e752 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e755 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e758 class=n-a></a>76%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e762 class=n-a></a>79%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e765 class=n-a></a>-</td></tr><tr><a name=d68666e768 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e769 class=n-a></a>Liu <i>et al</i>. (2015)<sup><a href="#ref-89">89</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e778 class=n-a></a>VEGF-C</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e781 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e784 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e787 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e790 class=n-a></a>71%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e794 class=n-a></a>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e797 class=n-a></a>0.79</td></tr><tr><a name=d68666e801 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e802 class=n-a></a>Liu <i>et al</i>. (2015)<sup><a href="#ref-89">89</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e811 class=n-a></a>VEGF-D</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e814 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e817 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e820 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e823 class=n-a></a>74%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e827 class=n-a></a>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e830 class=n-a></a>0.84</td></tr><tr><a name=d68666e833 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e834 class=n-a></a>Huang <i>et al</i>. (2015)<sup><a href="#ref-90">90</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e843 class=n-a></a>CYFRA 21-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e846 class=n-a></a>134</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e849 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e852 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e855 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e859 class=n-a></a>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e862 class=n-a></a>-</td></tr><tr><a name=d68666e865 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e866 class=n-a></a>Lumachi <i>et al</i>. (2014)<sup><a href="#ref-87">87</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e875 class=n-a></a>MMP7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e878 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e881 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e884 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e887 class=n-a></a>78%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e891 class=n-a></a>77%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e894 class=n-a></a>-</td></tr><tr><a name=d68666e897 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e898 class=n-a></a>Nigam <i>et al</i>. (2014)<sup><a href="#ref-91">91</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e907 class=n-a></a>Survivin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e910 class=n-a></a>39 (gallbladder<br class=br>cancer)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e915 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e918 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e921 class=n-a></a>81%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e925 class=n-a></a>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e928 class=n-a></a>-</td></tr><tr><a name=d68666e931 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e932 class=n-a></a>Rucksaken <i>et al</i>. (2014)<sup><a href="#ref-92">92</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e941 class=n-a></a>HSP70 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e944 class=n-a></a>31<br class=br></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e948 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e951 class=n-a></a>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e954 class=n-a></a>94%<br class=br></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e959 class=n-a></a>74%<br class=br></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e963 class=n-a></a>0.92<br class=br></td></tr><tr><a name=d68666e967 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e968 class=n-a></a>Rucksaken <i>et al</i>. (2014)<sup><a href="#ref-92">92</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e977 class=n-a></a>ENO1 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e980 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e983 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e986 class=n-a></a>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e989 class=n-a></a>81%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e993 class=n-a></a>78%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e996 class=n-a></a>0.86</td></tr><tr><a name=d68666e1000 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1001 class=n-a></a>Rucksaken <i>et al</i>. (2014)<sup><a href="#ref-92">92</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1010 class=n-a></a>RNH1 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1013 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1016 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1019 class=n-a></a>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1022 class=n-a></a>94%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1026 class=n-a></a>67%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1029 class=n-a></a>0.84</td></tr><tr><a name=d68666e1032 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1033 class=n-a></a>Wang <i>et al</i>. (2014)<sup><a href="#ref-88">88</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1042 class=n-a></a>CA242 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1045 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1048 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1051 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1054 class=n-a></a>64%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1058 class=n-a></a>99%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1061 class=n-a></a>-</td></tr><tr><a name=d68666e1064 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1065 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1074 class=n-a></a>VEGFR3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1077 class=n-a></a>96</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1080 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1083 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1086 class=n-a></a>48%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1090 class=n-a></a>82%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1093 class=n-a></a>0.62</td></tr><tr><a name=d68666e1096 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1097 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1106 class=n-a></a>TAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1109 class=n-a></a>96</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1112 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1115 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1118 class=n-a></a>61%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1122 class=n-a></a>60%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1125 class=n-a></a>0.60</td></tr><tr><a name=d68666e1128 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1129 class=n-a></a>Rucksaken <i>et al</i>. (2017)<sup><a href="#ref-94">94</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1138 class=n-a></a>ORM2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1141 class=n-a></a>70</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1144 class=n-a></a>46</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1147 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1150 class=n-a></a>92%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1154 class=n-a></a>74%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1157 class=n-a></a>-</td></tr><tr><a name=d68666e1160 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1161 class=n-a></a>Rose <i>et al</i>. (2016)<sup><a href="#ref-95">95</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1170 class=n-a></a>CEACAM6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1173 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1176 class=n-a></a>42</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1179 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1182 class=n-a></a>87.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1186 class=n-a></a>69%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1189 class=n-a></a>0.74</td></tr><tr><a name=d68666e1193 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1194 class=n-a></a>Jiao <i>et al</i>. (2014)<sup><a href="#ref-96">96</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1203 class=n-a></a>Nucleosides</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1206 class=n-a></a>202 (gallbladder<br class=br>cancer)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1211 class=n-a></a>203</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1214 class=n-a></a>205</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1217 class=n-a></a>91%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1221 class=n-a></a>96%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1224 class=n-a></a>-</td></tr><tr><a name=d68666e1227 class=n-a></a><td align=left colspan=8 rowspan=1 valign=top><a name=d68666e1228 class=n-a></a>Biomarker combinations</td></tr><tr><a name=d68666e1231 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1232 class=n-a></a>Lumachi <i>et al</i>. (2014)<sup><a href="#ref-87">87</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1241 class=n-a></a>CEA + CA19-9 +<br class=br>CYFRA 21-1 + MMP7</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1246 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1249 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1252 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1255 class=n-a></a>92%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1259 class=n-a></a>96%</td><td colspan=1 rowspan=1><a name=d68666e1262 class=n-a></a></td></tr></tbody></table></div><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Serum protein biomarkers for pancreatic cancer, 2012–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e1280 class=n-a></a><thead><a name=d68666e1282 class=n-a></a><tr><a name=d68666e1284 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1285 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1288 class=n-a></a>Biomarker/<br class=br>Combination<br class=br>(serum)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1295 class=n-a></a>PDAC, number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1298 class=n-a></a>Benign<br class=br>controls,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1305 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1312 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1316 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e1319 class=n-a></a>Area<br class=br>under<br class=br>the<br class=br>curve</th></tr></thead><tbody><a name=d68666e1329 class=n-a></a><tr><a name=d68666e1331 class=n-a></a><td align=left colspan=8 rowspan=1 valign=top><a name=d68666e1332 class=n-a></a>Single biomarkers</td></tr><tr><a name=d68666e1335 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1336 class=n-a></a>Sogawa <i>et al</i>. (2016)<sup><a href="#ref-97">97</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1345 class=n-a></a>C4BPA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1348 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1351 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1354 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1357 class=n-a></a>67%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1361 class=n-a></a>95%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1364 class=n-a></a>0.860</td></tr><tr><a name=d68666e1367 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1368 class=n-a></a>Rychlikova <i>et al</i>. (2016)<sup><a href="#ref-98">98</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1377 class=n-a></a>Osteopontin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1380 class=n-a></a>64</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1383 class=n-a></a>71</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1386 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1389 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1393 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1396 class=n-a></a>-</td></tr><tr><a name=d68666e1399 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1400 class=n-a></a>Lin <i>et al</i>. (2016)<sup><a href="#ref-99">99</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1409 class=n-a></a>APOA-I</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1412 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1415 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1418 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1421 class=n-a></a>96%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1425 class=n-a></a>72.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1428 class=n-a></a>0.880</td></tr><tr><a name=d68666e1431 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1432 class=n-a></a>Lin <i>et al</i>. (2016)<sup><a href="#ref-99">99</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1441 class=n-a></a>TF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1444 class=n-a></a>78</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1447 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1450 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1453 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1457 class=n-a></a>72.8%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1460 class=n-a></a>0.760</td></tr><tr><a name=d68666e1464 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1465 class=n-a></a>Guo <i>et al</i>. (2016)<sup><a href="#ref-100">100</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1474 class=n-a></a>Dysbindin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1477 class=n-a></a>250</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1480 class=n-a></a>80 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1483 class=n-a></a>150</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1486 class=n-a></a>81.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1490 class=n-a></a>84.7%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1493 class=n-a></a>0.849</td></tr><tr><a name=d68666e1496 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1497 class=n-a></a>Han <i>et al</i>. (2015)<sup><a href="#ref-101">101</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1506 class=n-a></a>Dickkopf-1 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1509 class=n-a></a>140</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1512 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1515 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1518 class=n-a></a>89.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1522 class=n-a></a>79.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1525 class=n-a></a>0.919</td></tr><tr><a name=d68666e1528 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1529 class=n-a></a>Qu <i>et al</i>. (2015)<sup><a href="#ref-102">102</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1538 class=n-a></a>DCLK1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1541 class=n-a></a>74</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1544 class=n-a></a>74</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1547 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1550 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1554 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1557 class=n-a></a>0.740</td></tr><tr><a name=d68666e1560 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1561 class=n-a></a>Dong <i>et al</i>. (2015)<sup><a href="#ref-103">103</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1570 class=n-a></a>Survivin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1573 class=n-a></a>80</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1576 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1579 class=n-a></a>80</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1582 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1586 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1589 class=n-a></a>-</td></tr><tr><a name=d68666e1592 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1593 class=n-a></a>Gebauer <i>et al</i>. (2014)<sup><a href="#ref-104">104</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1602 class=n-a></a>EpCAM</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1605 class=n-a></a>66</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1608 class=n-a></a>43</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1611 class=n-a></a>104</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1614 class=n-a></a>66.7%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1618 class=n-a></a>77.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1621 class=n-a></a>-</td></tr><tr><a name=d68666e1624 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1625 class=n-a></a>Wang <i>et al</i>. (2014)<sup><a href="#ref-105">105</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1634 class=n-a></a>MIC-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1637 class=n-a></a>807</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1640 class=n-a></a>165</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1643 class=n-a></a>500</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1646 class=n-a></a>65.8%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1650 class=n-a></a>96.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1653 class=n-a></a>0.935</td></tr><tr><a name=d68666e1657 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1658 class=n-a></a>Kendrick <i>et al</i>. (2014)<sup><a href="#ref-106">106</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1667 class=n-a></a>IGFBP2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1670 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1673 class=n-a></a>40 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1676 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1679 class=n-a></a>22%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1683 class=n-a></a>95%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1686 class=n-a></a>0.655</td></tr><tr><a name=d68666e1689 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1690 class=n-a></a>Kendrick <i>et al</i>. (2014)<sup><a href="#ref-106">106</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1699 class=n-a></a>MSLN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1702 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1705 class=n-a></a>40 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1708 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1711 class=n-a></a>17%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1715 class=n-a></a>95%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1718 class=n-a></a>0.668</td></tr><tr><a name=d68666e1721 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1722 class=n-a></a>Kang <i>et al</i>. (2014)<sup><a href="#ref-107">107</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1731 class=n-a></a>COL6A3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1734 class=n-a></a>44</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1737 class=n-a></a>46</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1740 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1743 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1747 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1750 class=n-a></a>0.975</td></tr><tr><a name=d68666e1753 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1754 class=n-a></a>Willumsen <i>et al</i>. (2013)<sup><a href="#ref-108">108</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1763 class=n-a></a>C1M</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1766 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1769 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1772 class=n-a></a>33</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1775 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1779 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1782 class=n-a></a>0.830</td></tr><tr><a name=d68666e1785 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1786 class=n-a></a>Willumsen <i>et al</i>. (2013)<sup><a href="#ref-108">108</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1795 class=n-a></a>C3M</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1798 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1801 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1804 class=n-a></a>33</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1807 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1811 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1814 class=n-a></a>0.880</td></tr><tr><a name=d68666e1817 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1818 class=n-a></a>Willumsen <i>et al</i>. (2013)<sup><a href="#ref-108">108</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1827 class=n-a></a>C4M</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1830 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1833 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1836 class=n-a></a>33</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1839 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1843 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1846 class=n-a></a>0.940</td></tr><tr><a name=d68666e1850 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1851 class=n-a></a>Willumsen <i>et al</i>. (2013)<sup><a href="#ref-108">108</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1860 class=n-a></a>C4M12a1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1863 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1866 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1869 class=n-a></a>33</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1872 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1876 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1879 class=n-a></a>0.890</td></tr><tr><a name=d68666e1882 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1883 class=n-a></a>Falco <i>et al</i>. (2013)<sup><a href="#ref-109">109</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1892 class=n-a></a>BAG3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1895 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1898 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1901 class=n-a></a>44</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1904 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1908 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1911 class=n-a></a>0.770</td></tr><tr><a name=d68666e1914 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1915 class=n-a></a>Falco <i>et al</i>. (2013)<sup><a href="#ref-109">109</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1924 class=n-a></a>BAG3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1927 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1930 class=n-a></a>17 (chronic<br class=br>pancreatitis)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1935 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1938 class=n-a></a>81%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1942 class=n-a></a>77%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1945 class=n-a></a>0.810</td></tr><tr><a name=d68666e1948 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1949 class=n-a></a>Chen <i>et al</i>. (2013)<sup><a href="#ref-110">110</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1958 class=n-a></a>TTR</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1961 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1964 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1967 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1970 class=n-a></a>91%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1974 class=n-a></a>47%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1977 class=n-a></a>0.730</td></tr><tr><a name=d68666e1980 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1981 class=n-a></a>Gold <i>et al</i>. (2013)<sup><a href="#ref-111">111</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1990 class=n-a></a>PAM4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1993 class=n-a></a>298</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1996 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e1999 class=n-a></a>79</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2002 class=n-a></a>76%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2006 class=n-a></a>96%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2009 class=n-a></a>-</td></tr><tr><a name=d68666e2012 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2013 class=n-a></a>Gold <i>et al</i>. (2013)<sup><a href="#ref-111">111</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2022 class=n-a></a>PAM4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2025 class=n-a></a>298</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2028 class=n-a></a>120</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2031 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2034 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2038 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2041 class=n-a></a>0.890</td></tr><tr><a name=d68666e2045 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2046 class=n-a></a>Poruk <i>et al</i>. (2013)<sup><a href="#ref-112">112</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2055 class=n-a></a>OPN</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2058 class=n-a></a>86</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2061 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2064 class=n-a></a>86</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2067 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2071 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2074 class=n-a></a>0.720</td></tr><tr><a name=d68666e2077 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2078 class=n-a></a>Poruk <i>et al</i>. (2013)<sup><a href="#ref-112">112</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2087 class=n-a></a>TIMP-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2090 class=n-a></a>86</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2093 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2096 class=n-a></a>86</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2099 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2103 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2106 class=n-a></a>0.770</td></tr><tr><a name=d68666e2109 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2110 class=n-a></a>Lee <i>et al.</i> (2014)<sup><a href="#ref-113">113</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2119 class=n-a></a>CA 19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2122 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2125 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2128 class=n-a></a>44</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2131 class=n-a></a>80.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2135 class=n-a></a>70%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2138 class=n-a></a>0.833</td></tr><tr><a name=d68666e2141 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2142 class=n-a></a>Lee <i>et al.</i> (2014)<sup><a href="#ref-113">113</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2151 class=n-a></a>Human<br class=br>complement<br class=br>factor B (CFB)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2158 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2161 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2164 class=n-a></a>44</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2167 class=n-a></a>73.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2171 class=n-a></a>97.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2174 class=n-a></a>0.958</td></tr><tr><a name=d68666e2177 class=n-a></a><td align=left colspan=8 rowspan=1 valign=top><a name=d68666e2178 class=n-a></a>Mixed cohorts</td></tr><tr><a name=d68666e2181 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2182 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2191 class=n-a></a>CEA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2194 class=n-a></a>96 (41 PDAC +25 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2197 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2200 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2203 class=n-a></a>42.7%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2207 class=n-a></a>89.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2210 class=n-a></a>0.713</td></tr><tr><a name=d68666e2214 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2215 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2224 class=n-a></a>CA19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2227 class=n-a></a>96 (41 PDAC +25 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2230 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2233 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2236 class=n-a></a>49%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2240 class=n-a></a>84.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2243 class=n-a></a>0.701</td></tr><tr><a name=d68666e2246 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2247 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2256 class=n-a></a>VEGFR3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2259 class=n-a></a>96 (41 PDAC +25 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2262 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2265 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2268 class=n-a></a>48.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2272 class=n-a></a>82.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2275 class=n-a></a>0.622</td></tr><tr><a name=d68666e2278 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2279 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2288 class=n-a></a>Total antioxidant<br class=br>capacity</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2293 class=n-a></a>96 (41 PDAC +25 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2296 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2299 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2302 class=n-a></a>61.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2306 class=n-a></a>60.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2309 class=n-a></a>0.602</td></tr><tr><a name=d68666e2312 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2313 class=n-a></a>Abdel-Razik <i>et al</i>. (2016)<sup><a href="#ref-114">114</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2322 class=n-a></a>IGF-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2325 class=n-a></a>47 (25 PDAC + 18 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2328 class=n-a></a>62</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2331 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2334 class=n-a></a>62%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2338 class=n-a></a>51%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2341 class=n-a></a>0.605</td></tr><tr><a name=d68666e2344 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2345 class=n-a></a>Abdel-Razik <i>et al</i>. (2016)<sup><a href="#ref-114">114</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2354 class=n-a></a>VEGF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2357 class=n-a></a>47 (25 PDAC + 18 BTC)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2360 class=n-a></a>62</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2363 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2366 class=n-a></a>58.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2370 class=n-a></a>57.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2373 class=n-a></a>0.544</td></tr><tr><a name=d68666e2376 class=n-a></a><td align=left colspan=8 rowspan=1 valign=top><a name=d68666e2377 class=n-a></a>Biomarker combinations</td></tr><tr><a name=d68666e2381 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2382 class=n-a></a>Chen <i>et al</i>. (2013)<sup><a href="#ref-110">110</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2391 class=n-a></a>TTR + CA19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2394 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2397 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2400 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2403 class=n-a></a>81%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2407 class=n-a></a>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2410 class=n-a></a>0.910</td></tr><tr><a name=d68666e2413 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2414 class=n-a></a>Lee <i>et al</i>. (2014)<sup><a href="#ref-113">113</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2423 class=n-a></a>CA19-9 + CFB</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2426 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2429 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2432 class=n-a></a>44</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2435 class=n-a></a>90.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2439 class=n-a></a>97.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2442 class=n-a></a>0.986</td></tr><tr><a name=d68666e2445 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2446 class=n-a></a>Sogawa <i>et al</i>. (2016)<sup><a href="#ref-97">97</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2455 class=n-a></a>C4BPA + CA19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2458 class=n-a></a>52</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2461 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2464 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2467 class=n-a></a>86%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2471 class=n-a></a>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2474 class=n-a></a>0.930</td></tr><tr><a name=d68666e2477 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2478 class=n-a></a>Makawita <i>et al</i>. (2013)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2487 class=n-a></a>CA19-9 + REG1B</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2490 class=n-a></a>100</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2493 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2496 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2499 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2503 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2506 class=n-a></a>0.880</td></tr><tr><a name=d68666e2509 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2510 class=n-a></a>Makawita <i>et al</i>. (2013)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2519 class=n-a></a>CA19-9 + SYCN<br class=br>+ REG1B</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2524 class=n-a></a>100</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2527 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2530 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2533 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2537 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2540 class=n-a></a>0.870</td></tr><tr><a name=d68666e2543 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2544 class=n-a></a>Willumsen <i>et al</i>. (2013)<sup><a href="#ref-108">108</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2553 class=n-a></a>C1M + C3M +<br class=br>C4M + C4M12a1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2558 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2561 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2564 class=n-a></a>33</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2567 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2571 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2574 class=n-a></a>0.990</td></tr><tr><a name=d68666e2578 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2579 class=n-a></a>Shaw <i>et al</i>. (2014)<sup><a href="#ref-116">116</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2588 class=n-a></a>IL10 + IL6 +<br class=br>PDGF + Ca19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2593 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2596 class=n-a></a>45 (benign)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2599 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2602 class=n-a></a>93%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2606 class=n-a></a>58%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2609 class=n-a></a>0.840<br class=br></td></tr><tr><a name=d68666e2613 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2614 class=n-a></a>Shaw <i>et al</i>. (2014)<sup><a href="#ref-116">116</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2623 class=n-a></a>IL8 + IL6 +<br class=br>IL-10 + Ca19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2628 class=n-a></a>84</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2631 class=n-a></a>32 (chronic<br class=br>pancreatitis)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2636 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2639 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2643 class=n-a></a>91%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2646 class=n-a></a>0.880<br class=br></td></tr><tr><a name=d68666e2650 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2651 class=n-a></a>Shaw <i>et al</i>. (2014)<sup><a href="#ref-116">116</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2660 class=n-a></a>IL8 + IL1b +<br class=br>Ca 19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2665 class=n-a></a>127</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2668 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2671 class=n-a></a>45</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2674 class=n-a></a>94%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2678 class=n-a></a>100%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2681 class=n-a></a>0.857</td></tr><tr><a name=d68666e2684 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2685 class=n-a></a>Brand <i>et al</i>. (2011)<sup><a href="#ref-117">117</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2694 class=n-a></a>Ca-19 + CEA +<br class=br>TIMP-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2699 class=n-a></a>173</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2702 class=n-a></a>70</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2705 class=n-a></a>120</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2708 class=n-a></a>71%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2712 class=n-a></a>89%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2715 class=n-a></a>-</td></tr><tr><a name=d68666e2718 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2719 class=n-a></a>Capello <i>et al</i>. (2017)<sup><a href="#ref-118">118</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2728 class=n-a></a>TIMP1 + LRG1<br class=br>+ Ca19-9 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2733 class=n-a></a>73</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2736 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2739 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2742 class=n-a></a>0.849%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2746 class=n-a></a>0.633%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2749 class=n-a></a>0.949</td></tr><tr><a name=d68666e2752 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2753 class=n-a></a>Capello <i>et al</i>. (2017)<sup><a href="#ref-118">118</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2762 class=n-a></a>TIMP1 + LRG1<br class=br>+ Ca19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2767 class=n-a></a>73</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2770 class=n-a></a>74</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2773 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2776 class=n-a></a>0.452%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2780 class=n-a></a>0.541%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2783 class=n-a></a>0.890</td></tr><tr><a name=d68666e2787 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2788 class=n-a></a>Chan <i>et al</i>. (2014)<sup><a href="#ref-119">119</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2797 class=n-a></a>Ca19-9 + Ca125<br class=br>+ LAMC2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2802 class=n-a></a>139</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2805 class=n-a></a>65</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2808 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2811 class=n-a></a>82%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2815 class=n-a></a>74%%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2818 class=n-a></a>0.870</td></tr><tr><a name=d68666e2821 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2822 class=n-a></a>Makawita <i>et al</i>. (2013)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2831 class=n-a></a>CA19-9 + REG1B</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2834 class=n-a></a>82</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2837 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2840 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2843 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2847 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2850 class=n-a></a>0.875</td></tr><tr><a name=d68666e2853 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2854 class=n-a></a>Makawita <i>et al</i>. (2013)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2863 class=n-a></a>CA19-9 + SYNC<br class=br>+ REG1B</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2868 class=n-a></a>82</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2871 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2874 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2877 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2881 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2884 class=n-a></a>0.873</td></tr><tr><a name=d68666e2887 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2888 class=n-a></a>Makawita <i>et al</i>. (2013)<sup><a href="#ref-115">115</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2897 class=n-a></a>CA19-9 + AGR2<br class=br>+ REG1B</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2902 class=n-a></a>82</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2905 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2908 class=n-a></a>92</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2911 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2915 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e2918 class=n-a></a>0.869</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d68666e2925 class=n-a></a><p id=d68666e2927> BTC, biliary tract cancer; PDAC, pancreatic ductal adenocarcinoma.</p></div></div></div><p class="" id=d68666e2933>In pancreaticobiliary malignancy and PDAC in particular, metastatic disease occurs at a very early stage in tumour development. This is demonstrated by the fact that patients who underwent resection of small primary tumours (&lt;2 cm) with no clinical evidence of metastatic disease had a 5-year survival after pancreatectomy of less than 18% owing to recurrent metastatic disease<sup><a href="#ref-39">39</a></sup>. Tumour development is driven by a series of cumulative genetic abnormalities; therefore, genetic and epigenetic changes have been explored as diagnostic targets in circulating tumour cells, cell-free DNA (cfDNA) and non-coding RNA (<a href="#T3">Table 3</a>–<a href="#T5">Table 5</a>). Owing to the position and composition of pancreaticobiliary tumours, tissue samples are frequently acellular, making diagnostics challenging. Recently, the utility of next-generation sequencing was explored as a technique that allows the detection of low-abundance mutations and abnormalities in small amounts of material<sup><a href="#ref-40">40</a></sup>. Changes in the metabalome are also being explored as a potential diagnostic tool in pancreaticobiliary malignancy<sup><a href="#ref-41">41</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Genetic and epigenetic alterations in circulating tumour cells in pancreatic ductal adenocarcinoma and biliary tract cancer, 2013–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e2965 class=n-a></a><thead><a name=d68666e2967 class=n-a></a><tr><a name=d68666e2969 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e2971 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e2974 class=n-a></a>Target</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e2977 class=n-a></a>Biliary<br class=br>tract<br class=br>cancer,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e2986 class=n-a></a>Pancreatic ductal<br class=br>adenocarcinoma,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e2993 class=n-a></a>Benign<br class=br>lesions,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3001 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3008 class=n-a></a>Detected</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3011 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3014 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3017 class=n-a></a>Area<br class=br>under<br class=br>the<br class=br>curve</th></tr></thead><tbody><a name=d68666e3028 class=n-a></a><tr><a name=d68666e3030 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3032 class=n-a></a>Ankeny <i>et al</i>. (2016)<sup><a href="#ref-120">120</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3041 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3044 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3047 class=n-a></a>72</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3050 class=n-a></a>28</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3054 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3057 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3060 class=n-a></a>75%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3063 class=n-a></a>96.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3066 class=n-a></a>0.867</td></tr><tr><a name=d68666e3070 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3072 class=n-a></a>Kulemann <i>et al</i>. (2016)<sup><a href="#ref-121">121</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3081 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3084 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3087 class=n-a></a>21</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3090 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3094 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3097 class=n-a></a>80% (stage IIA/IIB)<br class=br>91% (stage III/IV)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3102 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3105 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3108 class=n-a></a>-</td></tr><tr><a name=d68666e3112 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3114 class=n-a></a>Singh <i>et al</i>. (2015)<sup><a href="#ref-122">122</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3123 class=n-a></a>ctDNA,<br class=br>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3128 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3131 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3134 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3138 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3141 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3144 class=n-a></a>65.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3147 class=n-a></a>61.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3150 class=n-a></a>0.6681</td></tr><tr><a name=d68666e3154 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3156 class=n-a></a>Kinugasa <i>et al</i>. (2015)<sup><a href="#ref-123">123</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3165 class=n-a></a>K-ras </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3168 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3171 class=n-a></a>141</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3174 class=n-a></a>20 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3178 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3181 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3184 class=n-a></a>62.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3187 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3190 class=n-a></a>-</td></tr><tr><a name=d68666e3194 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3196 class=n-a></a>Takai <i>et al</i>. (2015)<sup><a href="#ref-124">124</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3205 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3208 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3211 class=n-a></a>259</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3214 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3218 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3221 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3224 class=n-a></a>29.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3227 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3230 class=n-a></a>-</td></tr><tr><a name=d68666e3235 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3237 class=n-a></a>Sausen <i>et al</i>. (2015)<sup><a href="#ref-125">125</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3246 class=n-a></a>ctDNA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3249 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3252 class=n-a></a>77</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3255 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3259 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3262 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3265 class=n-a></a>43%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3268 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3271 class=n-a></a>-</td></tr><tr><a name=d68666e3275 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3277 class=n-a></a>Kulemann <i>et al</i>. (2015)<sup><a href="#ref-126">126</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3286 class=n-a></a>CTC<br class=br>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3291 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3294 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3297 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3301 class=n-a></a>9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3304 class=n-a></a>75% (stage IIb)<br class=br>71% (stage III)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3309 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3312 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3315 class=n-a></a>-</td></tr><tr><a name=d68666e3319 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3321 class=n-a></a>Zhang <i>et al</i>. (2015)<sup><a href="#ref-127">127</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3330 class=n-a></a>DAPI<sup>+</sup>, CD45-,<br class=br>CK<sup>+</sup>,<br class=br>CEP8 &gt; 2<sup>+</sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3345 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3348 class=n-a></a>22<br class=br>Validation cohort:<br class=br>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3355 class=n-a></a>6<br class=br><br class=br>8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3362 class=n-a></a>30<br class=br><br class=br>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3368 class=n-a></a>68.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3371 class=n-a></a><br class=br><br class=br><br class=br>63.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3377 class=n-a></a><br class=br><br class=br><br class=br>94.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3383 class=n-a></a><br class=br><br class=br><br class=br>0.84</td></tr><tr><a name=d68666e3390 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3392 class=n-a></a>Wu <i>et al</i>. (2014)<sup><a href="#ref-128">128</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3401 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3404 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3407 class=n-a></a>36</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3410 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3414 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3417 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3420 class=n-a></a>0</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3423 class=n-a></a>0</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3426 class=n-a></a>-</td></tr><tr><a name=d68666e3430 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3432 class=n-a></a>Bidard <i>et al</i>. (2013)<sup><a href="#ref-129">129</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3441 class=n-a></a>CK,<br class=br>CD45</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3446 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3449 class=n-a></a>79</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3452 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3456 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3459 class=n-a></a>11%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3462 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3465 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3468 class=n-a></a>-</td></tr><tr><a name=d68666e3472 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3474 class=n-a></a>Bobek <i>et al</i>. (2014)<sup><a href="#ref-130">130</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3483 class=n-a></a>DAPI,<br class=br>CK,<br class=br>CEA, Vimentin</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3490 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3493 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3496 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3500 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3503 class=n-a></a>66.7%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3506 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3509 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3512 class=n-a></a>-</td></tr><tr><a name=d68666e3517 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3519 class=n-a></a>Rhim <i>et al</i>. (2014)<sup><a href="#ref-131">131</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3528 class=n-a></a>DAPI, CD45,<br class=br>CK,<br class=br>PDX-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3535 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3538 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3541 class=n-a></a>21 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3545 class=n-a></a>19</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3548 class=n-a></a>78% </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3551 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3554 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3557 class=n-a></a>-</td></tr><tr><a name=d68666e3561 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3563 class=n-a></a>Iwanicki-Caron <i>et al</i>. (2013)<sup><a href="#ref-132">132</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3572 class=n-a></a>CTC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3575 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3578 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3581 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3585 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3588 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3591 class=n-a></a>55.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3594 class=n-a></a>100%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3597 class=n-a></a>-</td></tr><tr><a name=d68666e3601 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3603 class=n-a></a>Sheng <i>et al</i>. (2014)<sup><a href="#ref-133">133</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3612 class=n-a></a>CTC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3615 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3618 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3621 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3625 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3628 class=n-a></a>94.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3631 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3634 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3637 class=n-a></a>-</td></tr><tr><a name=d68666e3641 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3643 class=n-a></a>Catebacci <i>et al</i>. (2015)<sup><a href="#ref-134">134</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3652 class=n-a></a>CTC (in portal venous<br class=br>blood at EUS)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3657 class=n-a></a>2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3660 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3663 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3667 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3670 class=n-a></a>100% (pulmonary vein blood)<br class=br>22.2% (peripheral blood)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3675 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3678 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3681 class=n-a></a>-</td></tr><tr><a name=d68666e3685 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3687 class=n-a></a>Earl <i>et al</i>. (2015)<sup><a href="#ref-135">135</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3696 class=n-a></a>CTC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3699 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3702 class=n-a></a>35</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3705 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3709 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3712 class=n-a></a>20%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3715 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3718 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3721 class=n-a></a>-</td></tr><tr><a name=d68666e3725 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3727 class=n-a></a>Cauley <i>et al</i>. (2015)<sup><a href="#ref-136">136</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3736 class=n-a></a>Circulating epithelial<br class=br>cells</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3741 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3744 class=n-a></a>105</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3747 class=n-a></a>34</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3751 class=n-a></a>9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3754 class=n-a></a>49%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3757 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3760 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3763 class=n-a></a>-</td></tr><tr><a name=d68666e3768 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3770 class=n-a></a>Kamande <i>et al</i>. (2013)<sup><a href="#ref-137">137</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3779 class=n-a></a>DAPI, CD45,<br class=br>CK</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3784 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3787 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3790 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3794 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3797 class=n-a></a>100%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3800 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3803 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3806 class=n-a></a>-</td></tr></tbody></table></div><div class="table-wrap panel clearfix"><a name=T4 class=n-a></a><div class=caption><h3>Table 4. Genetic and epigenetic alterations in circulating cell-free DNA pancreatic ductal adenocarcinoma and biliary tract cancer, 2013–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e3824 class=n-a></a><thead><a name=d68666e3826 class=n-a></a><tr><a name=d68666e3828 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3830 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3833 class=n-a></a>Target</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3836 class=n-a></a>PDAC<br class=br>or BTC</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3841 class=n-a></a>Cancer,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3846 class=n-a></a>Benign<br class=br>lesions,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3854 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3861 class=n-a></a>Detected</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3864 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e3867 class=n-a></a>Specificity</th></tr></thead><tbody><a name=d68666e3872 class=n-a></a><tr><a name=d68666e3874 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3876 class=n-a></a>Takai <i>et al</i>. (2016)<sup><a href="#ref-138">138</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3885 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3888 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3891 class=n-a></a>107 (non-<br class=br>operable)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3896 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3900 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3903 class=n-a></a>59%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3906 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3909 class=n-a></a>-</td></tr><tr><a name=d68666e3913 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3915 class=n-a></a>Takai <i>et al</i>. (2015)<sup><a href="#ref-124">124</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3924 class=n-a></a>cfDNA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3927 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3930 class=n-a></a>48</td><td colspan=1 rowspan=1><a name=d68666e3933 class=n-a></a></td><td colspan=1 rowspan=1><a name=d68666e3936 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3938 class=n-a></a>29%</td><td colspan=1 rowspan=1><a name=d68666e3941 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3943 class=n-a></a>&nbsp;</td></tr><tr><a name=d68666e3947 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3949 class=n-a></a>Hadano <i>et al</i>. (2016)<sup><a href="#ref-139">139</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3958 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3961 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3964 class=n-a></a>105</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3967 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3971 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3974 class=n-a></a>31%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3977 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3980 class=n-a></a>-</td></tr><tr><a name=d68666e3984 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3986 class=n-a></a>Zill <i>et al</i>. (2015)<sup><a href="#ref-140">140</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e3995 class=n-a></a>K-ras, TP53,<br class=br>APC, FBXW7,<br class=br>SMAD4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4002 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4005 class=n-a></a>26</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4008 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4012 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4015 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4018 class=n-a></a>92.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4021 class=n-a></a>100%</td></tr><tr><a name=d68666e4025 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4027 class=n-a></a>Earl <i>et al</i>. (2015)<sup><a href="#ref-135">135</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4036 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4039 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4042 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4045 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4049 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4052 class=n-a></a>26%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4055 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4058 class=n-a></a>-</td></tr><tr><a name=d68666e4063 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4065 class=n-a></a>Kinusaga <i>et al</i>. (2015)<sup><a href="#ref-123">123</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4074 class=n-a></a>G12V, G12D,<br class=br>and G12R in<br class=br>codon 12 of<br class=br>K-ras gene</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4083 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4086 class=n-a></a>141</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4089 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4093 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4096 class=n-a></a>62%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4099 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4102 class=n-a></a>-</td></tr><tr><a name=d68666e4106 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4108 class=n-a></a>Sausen <i>et al</i>. (2015)<sup><a href="#ref-125">125</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4117 class=n-a></a>cfDNA</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4120 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4123 class=n-a></a>77</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4126 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4130 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4133 class=n-a></a>43%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4136 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4139 class=n-a></a>-</td></tr><tr><a name=d68666e4143 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4145 class=n-a></a>Wu <i>et al</i>. (2014)<sup><a href="#ref-128">128</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4154 class=n-a></a>K-ras</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4157 class=n-a></a>PDAC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4160 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4163 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4167 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4170 class=n-a></a>72%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4173 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4176 class=n-a></a>-</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d68666e4184 class=n-a></a><p id=d68666e4186> BTC, biliary tract cancer; PDAC, pancreatic ductal adenocarcinoma.</p></div></div></div><div class="table-wrap panel clearfix"><a name=T5 class=n-a></a><div class=caption><h3>Table 5. Epigenetics: circulating non-coding RNA and DNA methylation markers in pancreatic ductal adenocarcinoma/biliary tract cancer, 2013–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e4203 class=n-a></a><thead><a name=d68666e4205 class=n-a></a><tr><a name=d68666e4207 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4209 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4212 class=n-a></a>MicroRNA</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4215 class=n-a></a>Biliary<br class=br>tract<br class=br>cancer,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4224 class=n-a></a>Pancreatic<br class=br>ductal<br class=br>adenocarcinoma,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4233 class=n-a></a>Benign<br class=br>lesions,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4241 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4248 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4251 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e4254 class=n-a></a>Area<br class=br>under<br class=br>the<br class=br>curve</th></tr></thead><tbody><a name=d68666e4265 class=n-a></a><tr><a name=d68666e4267 class=n-a></a><td align=left colspan=9 rowspan=1 valign=top><a name=d68666e4269 class=n-a></a>Circulating non-coding RNA</td></tr><tr><a name=d68666e4273 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4275 class=n-a></a>Kishimoto <i>et al</i>. (2013)<sup><a href="#ref-141">141</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4284 class=n-a></a>MiR-21 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4287 class=n-a></a>94<br class=br>94</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4292 class=n-a></a>-<br class=br>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4297 class=n-a></a>-<br class=br>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4303 class=n-a></a>50<br class=br>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4308 class=n-a></a>85%<br class=br>72.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4313 class=n-a></a>100%<br class=br>91.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4318 class=n-a></a>0.93<br class=br>0.83</td></tr><tr><a name=d68666e4324 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4326 class=n-a></a>Wang <i>et al</i>. (2013)<sup><a href="#ref-142">142</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4335 class=n-a></a>miR-27a-3p + CA19-9(↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4338 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4341 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4344 class=n-a></a>103</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4348 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4351 class=n-a></a>85.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4354 class=n-a></a>81.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4357 class=n-a></a>0.886</td></tr><tr><a name=d68666e4361 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4363 class=n-a></a>Kawaguchi <i>et al</i>. (2013)<sup><a href="#ref-143">143</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4372 class=n-a></a>miR-221 (↑),<br class=br>miR-375 (↓)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4377 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4380 class=n-a></a>47</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4383 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4387 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4390 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4393 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4396 class=n-a></a>0.762</td></tr><tr><a name=d68666e4400 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4402 class=n-a></a>Zhao <i>et al</i>. (2013)<sup><a href="#ref-144">144</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4411 class=n-a></a>miR-192 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4414 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4417 class=n-a></a>70</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4420 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4424 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4427 class=n-a></a>76%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4430 class=n-a></a>55%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4433 class=n-a></a>0.63</td></tr><tr><a name=d68666e4438 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4440 class=n-a></a>Carleson <i>et al</i>. (2013)<sup><a href="#ref-145">145</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4449 class=n-a></a>MiR-375 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4452 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4455 class=n-a></a>48</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4458 class=n-a></a>47 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4462 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4465 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4468 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4471 class=n-a></a>0.72</td></tr><tr><a name=d68666e4475 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4477 class=n-a></a>Que <i>et al</i>. (2013)<sup><a href="#ref-146">146</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4486 class=n-a></a>miR-17-5p (↑)<br class=br>miR-21 (↑), </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4491 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4494 class=n-a></a>22</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4497 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4501 class=n-a></a>8</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4504 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4507 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4510 class=n-a></a>0.887<br class=br>0.897</td></tr><tr><a name=d68666e4516 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4518 class=n-a></a>Schultz <i>et al</i>. (2014)<sup><a href="#ref-147">147</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4527 class=n-a></a>Index I + CA19-9<br class=br>Index II + CA19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4532 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4535 class=n-a></a>409</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4538 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4542 class=n-a></a>312</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4545 class=n-a></a>85%<br class=br>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4550 class=n-a></a>88%<br class=br>86%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4555 class=n-a></a>0.93<br class=br>0.92</td></tr><tr><a name=d68666e4561 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4563 class=n-a></a>Silakit <i>et al</i>. (2014)<sup><a href="#ref-148">148</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4572 class=n-a></a>MiR-192 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4575 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4578 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4581 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4585 class=n-a></a>9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4588 class=n-a></a>74%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4591 class=n-a></a>72%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4594 class=n-a></a>0.803</td></tr><tr><a name=d68666e4598 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4600 class=n-a></a>Lin <i>et al</i>. (2015)<sup><a href="#ref-149">149</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4609 class=n-a></a>MiR-492 (↑)<br class=br>MiR-663a (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4614 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4617 class=n-a></a>49</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4620 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4624 class=n-a></a>27</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4627 class=n-a></a>75%<br class=br>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4632 class=n-a></a>70%<br class=br>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4637 class=n-a></a>0.787<br class=br>0.870</td></tr><tr><a name=d68666e4643 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4645 class=n-a></a>Chen <i>et al</i>. (2014)<sup><a href="#ref-150">150</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4654 class=n-a></a>miR-182 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4657 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4660 class=n-a></a>109</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4663 class=n-a></a>38</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4667 class=n-a></a>50</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4670 class=n-a></a>64.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4673 class=n-a></a>82.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4676 class=n-a></a>0.775</td></tr><tr><a name=d68666e4681 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4683 class=n-a></a>Wang <i>et al</i>. (2015)<sup><a href="#ref-151">151</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4692 class=n-a></a>MiR-150 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4695 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4698 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4701 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4705 class=n-a></a>15</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4708 class=n-a></a>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4711 class=n-a></a>58%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4714 class=n-a></a>0.764</td></tr><tr><a name=d68666e4718 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4720 class=n-a></a>Ganepola <i>et al</i>. (2015)<sup><a href="#ref-152">152</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4729 class=n-a></a>miR-22 (↑),<br class=br>miR-642b (↑)<br class=br>miR-885-5p (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4736 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4739 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4742 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4746 class=n-a></a>11</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4749 class=n-a></a>91%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4752 class=n-a></a>91%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4755 class=n-a></a>0.970</td></tr><tr><a name=d68666e4759 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4761 class=n-a></a>Voigtlander <i>et al</i>. (2015)<sup><a href="#ref-153">153</a></sup><br class=br>(serum)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4772 class=n-a></a>MiR-1281 (↑)<br class=br>MiR-126 (↑)<br class=br>MiR-26a (↑)<br class=br>MiR-30b (↑)<br class=br>MiR-122 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4783 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4786 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4789 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4793 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4796 class=n-a></a>55%<br class=br>68%<br class=br>52%<br class=br>52%<br class=br>32%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4807 class=n-a></a>90%<br class=br>93%<br class=br>93%<br class=br>88%<br class=br>90%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4818 class=n-a></a>0.83<br class=br>0.87<br class=br>0.78<br class=br>0.78<br class=br>0.65</td></tr><tr><a name=d68666e4830 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4832 class=n-a></a>Voigtlander <i>et al</i>. (2015)<sup><a href="#ref-153">153</a></sup><br class=br>(bile)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4843 class=n-a></a>miR-412 (↑)<br class=br>miR-640 (↑)<br class=br>miR-1537 (↑)<br class=br>miR-3189 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4852 class=n-a></a>31</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4855 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4858 class=n-a></a>53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4862 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4865 class=n-a></a>50%<br class=br>50%<br class=br>67%<br class=br>67%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4874 class=n-a></a>89%<br class=br>92%<br class=br>90%<br class=br>89%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4883 class=n-a></a>0.81<br class=br>0.81<br class=br>0.78<br class=br>0.80</td></tr><tr><a name=d68666e4893 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4895 class=n-a></a>Abue <i>et al</i>. (2015)<sup><a href="#ref-154">154</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4904 class=n-a></a>miR-21 (↑),<br class=br>miR-483-3p (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4909 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4912 class=n-a></a>32</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4915 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4919 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4922 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4925 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4928 class=n-a></a>0.790<br class=br>0.754</td></tr><tr><a name=d68666e4934 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4936 class=n-a></a>Salter <i>et al</i>. (2015)<sup><a href="#ref-155">155</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4945 class=n-a></a>miR-196a (↑),<br class=br>miR-196b (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4950 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4953 class=n-a></a>19</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4956 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4960 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4963 class=n-a></a>100%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4966 class=n-a></a>90%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4969 class=n-a></a>0.99</td></tr><tr><a name=d68666e4974 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4976 class=n-a></a>Kojima <i>et al</i>. (2015)<sup><a href="#ref-156">156</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e4985 class=n-a></a>miR-6075,<br class=br>miR-4294,<br class=br>miR-6880-5p,<br class=br>miR-6799-5p,<br class=br>miR-125a-3p,<br class=br>miR-4530,<br class=br>miR-6836-3p,<br class=br>miR-4476</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5003 class=n-a></a>98</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5006 class=n-a></a>100</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5009 class=n-a></a>21</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5013 class=n-a></a>150</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5016 class=n-a></a>80.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5019 class=n-a></a>97.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5022 class=n-a></a>0.953</td></tr><tr><a name=d68666e5026 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5028 class=n-a></a>Xu <i>et al</i>. (2015)<sup><a href="#ref-157">157</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5037 class=n-a></a>miR-486-5p (↑)<br class=br>miR-938 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5042 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5045 class=n-a></a>156</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5048 class=n-a></a>142</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5052 class=n-a></a>65</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5055 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5058 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5061 class=n-a></a>0.861<br class=br>0.693</td></tr><tr><a name=d68666e5067 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5069 class=n-a></a>Madhaven <i>et al</i>. (2015)<sup><a href="#ref-158">158</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5078 class=n-a></a>PaCIC + miRNA<br class=br>serum-exosome<br class=br>marker panel</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5085 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5088 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5091 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5095 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5098 class=n-a></a>100%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5101 class=n-a></a>80%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5104 class=n-a></a>-</td></tr><tr><a name=d68666e5108 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5110 class=n-a></a>Komatsu <i>et al</i>. (2015)<sup><a href="#ref-159">159</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5119 class=n-a></a>miR-223 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5122 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5125 class=n-a></a>71</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5128 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5132 class=n-a></a>67</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5135 class=n-a></a>62%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5138 class=n-a></a>94.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5141 class=n-a></a>0.834</td></tr><tr><a name=d68666e5145 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5147 class=n-a></a>Alemar <i>et al</i>. (2016)<sup><a href="#ref-160">160</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5156 class=n-a></a>MiR-21 (↑)<br class=br>MiR-34a (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5161 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5164 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5167 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5171 class=n-a></a>10</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5174 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5177 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5180 class=n-a></a>0.889<br class=br>0.865</td></tr><tr><a name=d68666e5186 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5188 class=n-a></a>Wu <i>et al</i>. (2016)<sup><a href="#ref-161">161</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5197 class=n-a></a>MiR-150 (↓)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5200 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5203 class=n-a></a>30</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5206 class=n-a></a>28 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5210 class=n-a></a>50</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5213 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5216 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5219 class=n-a></a>-</td></tr><tr><a name=d68666e5224 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5226 class=n-a></a>Bernuzzi <i>et al</i>. (2016)<sup><a href="#ref-162">162</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5235 class=n-a></a>MiR-483-5p(↑)<br class=br>MiR-194(↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5240 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5243 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5246 class=n-a></a>70 </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5250 class=n-a></a>40</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5253 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5256 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5259 class=n-a></a>0.77<br class=br>0.74</td></tr><tr><a name=d68666e5265 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5267 class=n-a></a>Kim <i>et al</i>. (2016)<sup><a href="#ref-163">163</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5276 class=n-a></a>mRNA – CDH3 (↑)<br class=br>mRNA –IGF2BP3(↑)<br class=br>mRNA – HOXB7 (↑)<br class=br>mRNA – BIRC5 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5285 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5288 class=n-a></a>21</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5291 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5295 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5298 class=n-a></a>57.1%<br class=br>76.2%<br class=br>71.4%<br class=br>76.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5307 class=n-a></a>64.3%<br class=br>100%<br class=br>57.1%<br class=br>64.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5316 class=n-a></a>0.776<br class=br>0.476<br class=br>0.898<br class=br>0.818</td></tr><tr><a name=d68666e5326 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5328 class=n-a></a>Duell <i>et al</i>. (2017)<sup><a href="#ref-164">164</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5337 class=n-a></a>MiR-10a (↑)<br class=br>MiR-10b (↑)<br class=br>MiR-21-5p (↑)<br class=br>MiR-30c (↑)<br class=br>MiR-155 (↑)<br class=br>MiR-212 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5350 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5353 class=n-a></a>225</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5356 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5360 class=n-a></a>225</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5363 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5366 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5369 class=n-a></a>0.66<br class=br>0.68<br class=br>0.64<br class=br>0.71<br class=br>0.64<br class=br>0.64</td></tr><tr><a name=d68666e5383 class=n-a></a><td align=left colspan=9 rowspan=1 valign=top><a name=d68666e5385 class=n-a></a>DNA hypermethylation</td></tr><tr><a name=d68666e5389 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5391 class=n-a></a>Branchi <i>et al</i>. (2016)<sup><a href="#ref-165">165</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5400 class=n-a></a><i>SHOX2</i>/<i>SEPT9</i> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5408 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5411 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5414 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5418 class=n-a></a>100</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5421 class=n-a></a>0.45%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5424 class=n-a></a>0.99%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5427 class=n-a></a>0.752</td></tr></tbody></table></div></div><div class=section><a name=d68666e5435 class=n-a></a><h3 class=section-title>2. Bile and biliary brush biomarkers</h3><p class="" id=d68666e5440>Patients with an indeterminate stricture on cross-sectional imaging are typically referred for an ERCP and biliary brushing with or without endobilary biopsy to obtain tissue for diagnosis, with or without therapeutic stenting<sup><a href="#ref-28">28</a></sup>. Although these techniques do not compromise resection margins in potentially resectable cases, sensitivity remains low (9–57%) and patients frequently have to undergo multiple procedures to obtain a diagnosis<sup><a href="#ref-28">28</a>–<a href="#ref-30">30</a></sup>. Bile can be easily obtained at the time of ERCP and, owing to its proximity to the tumour, is a potentially important source of diagnostic biomarkers in these cancers (<a href="#T6">Table 6</a>). Unfortunately, owing to the invasiveness of ERCP, the role of these biomarkers is limited to diagnosis rather than screening or surveillance in these tumours.</p><div class="table-wrap panel clearfix"><a name=T6 class=n-a></a><div class=caption><h3>Table 6. Bile and biliary brush biomarkers for pancreatic and biliary tract cancer.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e5468 class=n-a></a><thead><a name=d68666e5470 class=n-a></a><tr><a name=d68666e5472 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5474 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5477 class=n-a></a>Biomarker</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5480 class=n-a></a>Pancreatic ductal<br class=br>adenocarcinoma,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5487 class=n-a></a>Biliary tract<br class=br>cancer,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5494 class=n-a></a>Benign<br class=br>lesions,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5502 class=n-a></a>Healthy<br class=br>controls,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5509 class=n-a></a>Bile or<br class=br>biliary<br class=br>brush</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5516 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5519 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e5522 class=n-a></a>Area<br class=br>under<br class=br>the<br class=br>curve</th></tr></thead><tbody><a name=d68666e5533 class=n-a></a><tr><a name=d68666e5535 class=n-a></a><td align=left colspan=10 rowspan=1 valign=top><a name=d68666e5537 class=n-a></a>Single biomarkers</td></tr><tr><a name=d68666e5541 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5543 class=n-a></a>Dhar <i>et al</i>. (2013)<sup><a href="#ref-166">166</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5552 class=n-a></a>M2-PK</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5555 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5558 class=n-a></a>88</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5561 class=n-a></a>79</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5565 class=n-a></a>17</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5568 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5571 class=n-a></a>90.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5574 class=n-a></a>84.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5577 class=n-a></a>-</td></tr><tr><a name=d68666e5581 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5583 class=n-a></a>Navaneethan<br class=br><i>et al</i>. (2015)<sup><a href="#ref-167">167</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5593 class=n-a></a>M2-PK</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5596 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5599 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5602 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5606 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5609 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5612 class=n-a></a>52.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5615 class=n-a></a>94.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5618 class=n-a></a>0.77</td></tr><tr><a name=d68666e5622 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5624 class=n-a></a>Keane (2017)<sup><a href="#ref-168">168</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5630 class=n-a></a>MCM5</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5633 class=n-a></a>24</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5636 class=n-a></a>17</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5639 class=n-a></a>47</td><td colspan=1 rowspan=1><a name=d68666e5643 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5645 class=n-a></a>Biliary<br class=br>brush </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5650 class=n-a></a>55.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5653 class=n-a></a>77.8%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5656 class=n-a></a>0.79</td></tr><tr><a name=d68666e5660 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5662 class=n-a></a>Danese <i>et al</i>.<br class=br>(2014)<sup><a href="#ref-169">169</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5673 class=n-a></a>MUC5AC</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5676 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5679 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5682 class=n-a></a>20</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5686 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5689 class=n-a></a>Serum<br class=br>Bile </td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5694 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5697 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5700 class=n-a></a>0.94<br class=br>0.99</td></tr><tr><a name=d68666e5707 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5709 class=n-a></a>Farina <i>et al</i>.<br class=br>(2014)<sup><a href="#ref-170">170</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5720 class=n-a></a>CEAM6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5723 class=n-a></a>23</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5726 class=n-a></a>6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5729 class=n-a></a>12</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5733 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5736 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5739 class=n-a></a>93%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5742 class=n-a></a>83%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5745 class=n-a></a>0.92</td></tr><tr><a name=d68666e5749 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5751 class=n-a></a>Budzynska <i>et al</i>.<br class=br>(2013)<sup><a href="#ref-171">171</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5762 class=n-a></a>NGAL</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5765 class=n-a></a>6</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5768 class=n-a></a>16</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5771 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5775 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5778 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5781 class=n-a></a>77%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5784 class=n-a></a>72%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5787 class=n-a></a>0.74</td></tr><tr><a name=d68666e5791 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5793 class=n-a></a>Jiao <i>et al</i>. (2014)<sup><a href="#ref-96">96</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5802 class=n-a></a>Nucleosides</td><td colspan=1 rowspan=1><a name=d68666e5805 class=n-a></a></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5807 class=n-a></a>202<br class=br>(gallbladder<br class=br>cancer)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5814 class=n-a></a>203</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5818 class=n-a></a>205</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5821 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5824 class=n-a></a>95.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5827 class=n-a></a>96.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5830 class=n-a></a>-</td></tr><tr><a name=d68666e5834 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5836 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5845 class=n-a></a>CE</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5848 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5851 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5854 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5858 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5861 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5864 class=n-a></a>57.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5867 class=n-a></a>68.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5870 class=n-a></a>0.516</td></tr><tr><a name=d68666e5874 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5876 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5885 class=n-a></a>CA 19-9</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5888 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5891 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5894 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5898 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5901 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5904 class=n-a></a>74.0%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5907 class=n-a></a>34.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5910 class=n-a></a>0.616</td></tr><tr><a name=d68666e5914 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5916 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5925 class=n-a></a>VEGFR3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5928 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5931 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5934 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5938 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5941 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5944 class=n-a></a>56.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5947 class=n-a></a>79.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5950 class=n-a></a>0.663</td></tr><tr><a name=d68666e5955 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5957 class=n-a></a>Ince <i>et al</i>. (2014)<sup><a href="#ref-93">93</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5966 class=n-a></a>Total antioxidant<br class=br>capacity</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5971 class=n-a></a>41</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5974 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5977 class=n-a></a>129</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5981 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5984 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5987 class=n-a></a>65.6%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5990 class=n-a></a>50.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5993 class=n-a></a>0.581</td></tr><tr><a name=d68666e5997 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e5999 class=n-a></a>Abdel-Razik <i>et al</i>.<br class=br>(2016)<sup><a href="#ref-114">114</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6010 class=n-a></a>IGF-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6013 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6016 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6019 class=n-a></a>62</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6023 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6026 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6029 class=n-a></a>91.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6032 class=n-a></a>89.5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6035 class=n-a></a>0.943</td></tr><tr><a name=d68666e6039 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6041 class=n-a></a>Abdel-Razik <i>et al</i>.<br class=br>(2016)<sup><a href="#ref-114">114</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6052 class=n-a></a>VEGF</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6055 class=n-a></a>25</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6058 class=n-a></a>18</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6061 class=n-a></a>62</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6065 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6068 class=n-a></a>Bile</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6071 class=n-a></a>90.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6074 class=n-a></a>84.9%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6077 class=n-a></a>0.915</td></tr><tr><a name=d68666e6081 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6083 class=n-a></a>Kim <i>et al</i>. (2016)<sup><a href="#ref-163">163</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6092 class=n-a></a>mRNA – CDH3 (↑)<br class=br>mRNA –IGF2BP3(↑)<br class=br>mRNA – HOXB7 (↑)<br class=br>mRNA – BIRC5 (↑)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6101 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6104 class=n-a></a>21</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6107 class=n-a></a>14</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6111 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6114 class=n-a></a>Biliary<br class=br>brush</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6119 class=n-a></a>57.1%<br class=br>76.2%<br class=br>71.4%<br class=br>76.2%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6128 class=n-a></a>64.3%<br class=br>100%<br class=br>57.1%<br class=br>64.3%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6137 class=n-a></a>0.776<br class=br>0.476<br class=br>0.898<br class=br>0.818</td></tr></tbody></table></div></div><div class=section><a name=d68666e6151 class=n-a></a><h3 class=section-title>3. Urinary biomarkers</h3><p class="" id=d68666e6156>Urine provides a very easy and acceptable source for biomarker analysis. In BTC, a 42-peptide panel (consisting mostly of fragments of interstitial collagens) correctly identified 35 of 42 BTC patients with a sensitivity of 83% and a specificity of 79%<sup><a href="#ref-42">42</a></sup>. In PDAC, the three-biomarker panel (LYVE-1, REG1A and TFF1) has been validated in a multi-centre cohort of 371 samples. When comparing PDAC stage I–IIA (resectable disease) with healthy urines, the panel achieved AUCs of 0.97 (95% confidence interval of 0.93–1.00). The performance of the urine biomarker panel in discriminating PDAC stage I–IIA was superior to the performance of serum CA19-9 (<i>P</i>=0.006)<sup><a href="#ref-43">43</a></sup> (<a href="#T7">Table 7</a>).</p><div class="table-wrap panel clearfix"><a name=T7 class=n-a></a><div class=caption><h3>Table 7. Summary of urine protein biomarkers for pancreatic and biliary tract cancer, 2013–2017.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d68666e6184 class=n-a></a><thead><a name=d68666e6186 class=n-a></a><tr><a name=d68666e6188 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6190 class=n-a></a>Author (year)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6193 class=n-a></a>Biomarker/<br class=br>Combination<br class=br>(urine)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6200 class=n-a></a>Pancreatic ductal<br class=br>adenocarcinoma,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6207 class=n-a></a>Biliary tract<br class=br>cancer,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6214 class=n-a></a>Benign<br class=br>cancer/<br class=br>Chronic<br class=br>pancreatitis,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6226 class=n-a></a>Healthy<br class=br>volunteers,<br class=br>number</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6233 class=n-a></a>Sensitivity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6236 class=n-a></a>Specificity</th><th align=left colspan=1 rowspan=1 valign=top><a name=d68666e6239 class=n-a></a>Area<br class=br>under<br class=br>the<br class=br>curve</th></tr></thead><tbody><a name=d68666e6250 class=n-a></a><tr><a name=d68666e6252 class=n-a></a><td align=left colspan=10 rowspan=1 valign=top><a name=d68666e6254 class=n-a></a>Single biomarker</td></tr><tr><a name=d68666e6258 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6260 class=n-a></a>Roy <i>et al</i>. (2014)<sup><a href="#ref-172">172</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6269 class=n-a></a>MMP2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6272 class=n-a></a>51</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6275 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6278 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6282 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6285 class=n-a></a>70%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6288 class=n-a></a>85%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6291 class=n-a></a>-</td></tr><tr><a name=d68666e6295 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6297 class=n-a></a>Roy <i>et al</i>. (2014)<sup><a href="#ref-172">172</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6306 class=n-a></a>TIMP-1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6309 class=n-a></a>51</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6312 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6315 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6319 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6322 class=n-a></a>90%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6325 class=n-a></a>70%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6328 class=n-a></a>-</td></tr><tr><a name=d68666e6332 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6334 class=n-a></a>Jiao <i>et al</i>. (2014)<sup><a href="#ref-96">96</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6343 class=n-a></a>Nucleosides</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6346 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6349 class=n-a></a>202<br class=br>(gallbladder<br class=br>cancer)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6356 class=n-a></a>203</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6360 class=n-a></a>205</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6363 class=n-a></a>89.4%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6366 class=n-a></a>97.1%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6369 class=n-a></a>-</td></tr><tr><a name=d68666e6373 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6375 class=n-a></a>Metzger <i>et al</i>. (2013)<sup><a href="#ref-42">42</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6384 class=n-a></a>Urine Proteomic<br class=br>analysis</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6389 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6392 class=n-a></a>42</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6395 class=n-a></a>81</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6399 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6402 class=n-a></a>83%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6405 class=n-a></a>79%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6408 class=n-a></a>0.87</td></tr><tr><a name=d68666e6413 class=n-a></a><td align=left colspan=10 rowspan=1 valign=top><a name=d68666e6415 class=n-a></a>Biomarker combinations</td></tr><tr><a name=d68666e6419 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6421 class=n-a></a>Radon <i>et al</i>. (2015)<sup><a href="#ref-43">43</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6430 class=n-a></a>LYVE-1 +<br class=br>REG1A + TFF1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6435 class=n-a></a>192</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6438 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6441 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6445 class=n-a></a>87</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6448 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6451 class=n-a></a>-</td><td align=left colspan=1 rowspan=1 valign=top><a name=d68666e6454 class=n-a></a>0.89</td></tr></tbody></table></div></div><div class=section><a name=d68666e6462 class=n-a></a><h3 class=section-title>4. Symptoms and cancer decision support tools</h3><p class="" id=d68666e6467>Recently, pre-diagnostic symptom profiles have been investigated as an alternative way of detecting hepato-pancreato-biliary (HPB) cancers at an early stage<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a>,<a href="#ref-16">16</a>,<a href="#ref-44">44</a></sup>. It is now recognised that the onset of PDAC and BTC is heralded by a collection of gastrointestinal and constitutional symptoms<sup><a href="#ref-45">45</a></sup>. Although overlap occurs with other benign and malignant conditions, certain symptoms such as back pain, lethargy and new-onset diabetes have been identified as particularly suggestive of PDAC. Commonly performed blood tests such as liver function tests, glucose and haemoglobin also typically become abnormal in the months preceding diagnosis<sup><a href="#ref-46">46</a></sup>. Therefore, cancer decision support tools have been produced from combinations of symptoms and risk factors. In the UK, they have been introduced into general practices in 15 cancer networks to date<sup><a href="#ref-8">8</a></sup>, and their utility is currently being audited<sup><a href="#ref-47">47</a></sup>. Modification to existing tools to enhance their diagnostic accuracy can be expected in the future.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e6503>Endoscopy</h2><div class=section><a name=d68666e6506 class=n-a></a><h3 class=section-title>1. Endoscopic ultrasonography</h3><p class="" id=d68666e6511>If there is a mass lesion on cross-sectional imaging, endoscopic ultrasonography with fine-needle aspiration (EUS-FNA) provides an alternative method for visualising and sampling the extra-hepatic biliary tree, pancreas, gallbladder or peri-hilar lymph nodes. EUS-FNA has a diagnostic accuracy for PDAC of between 65% and 96%<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. In BTC, a single-centre study reported a sensitivity of 73%, which was significantly better in distal compared with proximal tumours (81% versus 59% respectively, <i>P</i>=0.04)<sup><a href="#ref-50">50</a></sup>. Recently, developed fine core biopsy needles appear to have improved diagnostic accuracy over traditional FNA needles, but randomised trials are awaited<sup><a href="#ref-49">49</a>,<a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. Rapid onsite examination by a cytopathologist is used in some centres, particularly in North America, and has been shown to improve the yield of EUS-FNA in individual centres<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup> but this trend has not been borne out in recent randomised controlled trials<sup><a href="#ref-55">55</a></sup>.</p><p class="" id=d68666e6550>To improve the diagnostic accuracy of EUS, it can also be combined with novel adjuncts such as contrast agents (SonoVue<sup>®</sup>), transient elastography (TE) or confocal laser endomicroscopy (CLE). TE allows the measurement of the tissue firmness, which tends to be increased in malignant tissue. In a recent single-centre study from the UK, quantitative strain measurements were found to have high sensitivity but low specificity for the detection of PDAC<sup><a href="#ref-56">56</a></sup>. The technology to perform the techniques is available on most modern EUS machines and adds little time to the overall procedure time. The technique can be performed equally well by endosonographers with limited experience<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup> and is particularly advantageous in cases where the diagnosis remains uncertain after standard EUS has been performed<sup><a href="#ref-59">59</a></sup>. Contrast-enhanced EUS is performed with agents such as SonoVue<sup>®</sup> and allows visualisation of the early arterial phase and late parenchymal phase enhancement of the pancreas. Pancreatic tumours are generally hypovascular compared with the surrounding parenchyma<sup><a href="#ref-60">60</a>,<a href="#ref-61">61</a></sup>. Dynamic contrast EUS is a relatively novel method that allows the non-invasive quantification of the tumour perfusion compared with the pancreatic parenchyma by using software that is now built into a number of EUS scanners. The use of this technology is evolving but is expected to be most applicable when predicting tumour response to chemotherapeutic agents, particularly new drugs against vascular angioneogenesis<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>.</p><p class="" id=d68666e6589>Recently, a needle-based confocal endomicroscope has also been developed which can be passed through a 19G FNA needle to assess indeterminate masses, cysts or lymph nodes. Malignancy in the hepatobilary tract is identified by the presence of irregular vessels, vascular leakage and large dark clumps (<a href="#f1">Figure 1</a>)<sup><a href="#ref-64">64</a></sup>. In a recent study of 25 patients with indeterminate pancreatic masses referred for EUS-FNA, needle-based CLE was shown to be a safe and feasible technique<sup><a href="#ref-65">65</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12275/c518fadd-1bce-4e72-adbf-63d3c58c5af9_figure1.gif"><img alt="c518fadd-1bce-4e72-adbf-63d3c58c5af9_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12275/c518fadd-1bce-4e72-adbf-63d3c58c5af9_figure1.gif"></a><div class=caption><h3>Figure 1. Novel diagnostic adjuncts to ERCP and EUS.</h3><p id=d68666e6613>(<b>a</b>) Cholangioscopic view of a malignant hilar stricture with visualisation of the ulcerated, friable biliary mucosa via the Spyglass cholangioscope system (Boston Scientific Corp, Massachusetts, USA). (<b>b</b>) Confocal endomicroscopic image of pancreatic cancer, showing characteristic black clumps. Image was obtained using the Cellvizio AQ-Flex® probe which was introduced to the tumour via 19G FNA needle at the time of EUS.</p></div></div></div><div class=section><a name=d68666e6627 class=n-a></a><h3 class=section-title>2. Endoscopic retrograde cholangiopancreatography</h3><p class="" id=d68666e6632>ERCP is typically undertaken when imaging demonstrates an indeterminate biliary stricture and tissue acquisition is required for cytological or histological assessment. Biliary brush cytology and endobiliary biopsy have a sensitivity for malignancy of 9–57%<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a>,<a href="#ref-66">66</a>,<a href="#ref-67">67</a></sup>. Most HPB tumours exhibit chromosomal aneuploidy<sup><a href="#ref-68">68</a></sup>; therefore, in some centres, fluorescence <i>in situ</i> hybridisation and digital image analysis are used to assess for the presence of DNA abnormalities in brush cytology<sup><a href="#ref-30">30</a>,<a href="#ref-69">69</a></sup>. Although these techniques have been adopted by only a few centres, the presence of polysomy is highly suggestive of BTC<sup><a href="#ref-30">30</a>,<a href="#ref-69">69</a></sup>. </p><p class="" id=d68666e6669>Poor diagnostic accuracy in biliary brush and endobiliary samples has been attributed to their being non-targeted samples obtained with only fluoroscopic guidance<sup><a href="#ref-70">70</a></sup>. The single-operator cholangioscopy system (SpyGlass, Boston Scientific Corporation, Natick, MA, USA) introduced in 2006 and now superseded by the SpyGlass DS system enables intrabiliary biopsies under direct vision via small disposable forceps (<a href="#f1">Figure 1</a>). In a recent systematic review, the sensitivity and specificity of cholangioscopy-guided biopsies in the diagnosis of malignant biliary strictures were 60.1% and 98.0%, respectively<sup><a href="#ref-71">71</a></sup>. Higher sensitivities are observed for intrinsic biliary malignancy compared with extrinsic compressing tumours<sup><a href="#ref-72">72</a></sup>. Several techniques have been employed to augment the visualised mucosa during cholangioscopy, including chromendoscopy with methylene blue<sup><a href="#ref-73">73</a>–<a href="#ref-75">75</a></sup>, narrow-band imaging<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup> and autofluorescence<sup><a href="#ref-78">78</a></sup>.</p><p class="" id=d68666e6706>During ERCP, a “CholangioFlex” confocal probe (Mauna Kea Technologies, Paris, France) can be placed down the working channel of a cholangioscope or duodenoscope to obtain real-time CLE images, which are akin to standard histology (<a href="#f1">Figure 1</a>). If the images obtained from a point on the biliary mucosa contain dark areas, this is highly suggestive of malignancy<sup><a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>. The diagnostic accuracy of probe-based CLE was recently validated in a prospective multi-centre international study with 112 patients (71 with malignant lesions). Tissue sampling alone had a sensitivity, specificity and diagnostic accuracy of 56%, 100% and 72%, respectively. In comparison, ERCP with probe-based CLE had a sensitivity, specificity and diagnostic accuracy of 89%, 71% and 82%, respectively. Diagnostic accuracy increased to 88% when probe-based CLE and tissue sampling results were combined<sup><a href="#ref-81">81</a></sup>. CLE is also feasible in the pancreatic duct during pancreaticoscopy but, owing to concerns over pancreatitis, is rarely used. In a case report by Meining <i>et al</i>., the presence of a main duct-intraductal papillary mucinous neoplasia was confirmed by clear views of typical finger-like projections<sup><a href="#ref-82">82</a></sup>. Intraductal ultrasound in small studies has also been shown to have a diagnostic accuracy of up to 90%<sup><a href="#ref-83">83</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e6739>Conclusions</h2><p class="" id=d68666e6742>Currently, the most widely used tumour marker in pancreaticobiliary malignancy is CA19-9. However, its use is limited by its elevation in a number of other benign and malignant conditions. Furthermore, it is not produced in approximately 7% of the population who are Lewis antigen–negative and is often undetectable when tumours are small. Over the last few years, a number of very promising biomarker panels have been identified which can detect tumours at an early stage when curative intervention could be possible. These markers are subject to ongoing validation studies but appear likely to be implemented into screening programmes, particularly for high-risk groups, in the near future. Novel endoscopic techniques such as per-oral cholangioscopy and confocal endomicroscopy can enhance the diagnostic accuracy of standard techniques and are increasingly available in large-volume centres worldwide.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d68666e6749>Abbreviations</h2><p class="" id=d68666e6752>AUC, area under the curve; BTC, biliary tract cancer; CA, carbohydrate antigen; CEA, carcinoembryonic antigen; CLE, confocal laser endomicroscopy; ERCP, endoscopic retrograde cholangiopancreatography; EUS, endoscopic ultrasound; FNA, fine-needle aspiration; HPB, hepato-pancreato-biliary; PDAC, pancreatic ductal adenocarcinoma; TE, transient elastography.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d68666e1 class=n-a></a><h2 class=main-title id=d69199>Competing interests</h2><p class=metadata-entry><a name=d68666e126 class=n-a></a><p id=d68666e127> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d68666e1 class=n-a></a><h2 class=main-title id=d69201>Grant information</h2><p>SPP is supported in part by National Institutes of Health grant P01CA8420. Part of the work was undertaken at University College London Hospitals/University College London, which received a portion of funding from the Department of Health’s National Institute for Health Research Biomedical Research Centres funding scheme.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>. </p></div><div class=back-section><a name=d68666e6759 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d69772>References</h2><div class="section ref-list"><a name=d68666e6759 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d68666e6766 class=n-a></a>CRUK: Pancreatic cancer statistics. 2013. <a target=xrefwindow id=d68666e6768 href="http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/pancreatic-cancer">Reference Source</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d68666e6777 class=n-a></a>Khan SA, Toledano MB, Taylor-Robinson SD: Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. <i>HPB (Oxford).</i> 2008; <b>10</b>(2): 77–82. <a target=xrefwindow id=d68666e6785 href="http://www.ncbi.nlm.nih.gov/pubmed/18773060">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6788 href="http://dx.doi.org/10.1080/13651820801992641">Publisher Full Text </a> | <a target=xrefwindow id=d68666e6791 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2504381">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d68666e6800 class=n-a></a>CRUK: Cancer Research UK Cancer Stats Incidence 2008. 2011. <a target=xrefwindow id=d68666e6802 href="http://www.cancerresearchuk.org/about-us/prod_consump/groups/cr_common/@nre/@sta/documents/generalcontent/cr_072111.pdf">Reference Source</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d68666e6811 class=n-a></a>Coupland VH, Kocher HM, Berry DP, <i> et al.</i>: Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007. <i>Cancer Epidemiol.</i> 2012; <b>36</b>(4): e207–14. <a target=xrefwindow id=d68666e6822 href="http://www.ncbi.nlm.nih.gov/pubmed/22534487">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6825 href="http://dx.doi.org/10.1016/j.canep.2012.03.010">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d68666e6834 class=n-a></a>Altekruse SF, Kosary CL, Krapcho M, <i> et al.</i>: SEER Cancer Statistics. Review, 1975–2007. National Cancer Institute Bethesda, MD based on November 2009 SEER data submission, posted to the SEER web site, 2010. 2010. <a target=xrefwindow id=d68666e6839 href="https://seer.cancer.gov/archive/csr/1975_2007/">Reference Source</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d68666e6849 class=n-a></a>Curado MP, Edwards B, Shin HR, <i> et al.</i>: Cancer Incidence in Five Continents. IARC Scientific Publications No 160, 2007; <b>9</b>. <a target=xrefwindow id=d68666e6857 href="https://www.iarc.fr/en/publications/pdfs-online/epi/sp160/CI5vol9.pdf">Reference Source</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d68666e6866 class=n-a></a>Lichtenstein P, Holm NV, Verkasalo PK, <i> et al.</i>: Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. <i>N Engl J Med.</i> 2000; <b>343</b>(2): 78–85. <a target=xrefwindow id=d68666e6877 href="http://www.ncbi.nlm.nih.gov/pubmed/10891514">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6880 href="http://dx.doi.org/10.1056/NEJM200007133430201">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d68666e6889 class=n-a></a>Hippisley-Cox J, Coupland C: Identifying patients with suspected pancreatic cancer in primary care: derivation and validation of an algorithm. <i>Br J Gen Pract.</i> 2012; <b>62</b>(594): e38–45. <a target=xrefwindow id=d68666e6897 href="http://www.ncbi.nlm.nih.gov/pubmed/22520674">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6900 href="http://dx.doi.org/10.3399/bjgp12X616355">Publisher Full Text </a> | <a target=xrefwindow id=d68666e6903 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3252538">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d68666e6912 class=n-a></a>Stapley S, Peters TJ, Neal RD, <i> et al.</i>: The risk of pancreatic cancer in symptomatic patients in primary care: a large case-control study using electronic records. <i>Br J Cancer.</i> 2012; <b>106</b>(12): 1940–4. <a target=xrefwindow id=d68666e6923 href="http://www.ncbi.nlm.nih.gov/pubmed/22617126">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6926 href="http://dx.doi.org/10.1038/bjc.2012.190">Publisher Full Text </a> | <a target=xrefwindow id=d68666e6930 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3388562">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d68666e6939 class=n-a></a>Silverman DT, Dunn JA, Hoover RN, <i> et al.</i>: Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. <i>J Natl Cancer Inst.</i> 1994; <b>86</b>(20): 1510–6. <a target=xrefwindow id=d68666e6950 href="http://www.ncbi.nlm.nih.gov/pubmed/7932805">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6953 href="http://dx.doi.org/10.1093/jnci/86.20.1510">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d68666e6962 class=n-a></a>Fuchs CS, Colditz GA, Stampfer MJ, <i> et al.</i>: A prospective study of cigarette smoking and the risk of pancreatic cancer. <i>Arch Intern Med.</i> 1996; <b>156</b>(19): 2255–60. <a target=xrefwindow id=d68666e6973 href="http://www.ncbi.nlm.nih.gov/pubmed/8885826">PubMed Abstract </a> | <a target=xrefwindow id=d68666e6976 href="http://dx.doi.org/10.1001/archinte.1996.00440180119015">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d68666e6986 class=n-a></a>Muscat JE, Stellman SD, Hoffmann D, <i> et al.</i>: Smoking and pancreatic cancer in men and women. <i>Cancer Epidemiol Biomarkers Prev.</i> 1997; <b>6</b>(1): 15–9. <a target=xrefwindow id=d68666e6997 href="http://www.ncbi.nlm.nih.gov/pubmed/8993792">PubMed Abstract </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d68666e7006 class=n-a></a>Bonelli L, Aste H, Bovo P, <i> et al.</i>: Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: a case-control study in northern Italy. <i>Pancreas.</i> 2003; <b>27</b>(2): 143–9. <a target=xrefwindow id=d68666e7017 href="http://www.ncbi.nlm.nih.gov/pubmed/12883263">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7020 href="http://dx.doi.org/10.1097/00006676-200308000-00007">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d68666e7029 class=n-a></a>Larsson SC, Permert J, Håkansson N, <i> et al.</i>: Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. <i>Br J Cancer.</i> 2005; <b>93</b>(11): 1310–5. <a target=xrefwindow id=d68666e7040 href="http://www.ncbi.nlm.nih.gov/pubmed/16288300">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7043 href="http://dx.doi.org/10.1038/sj.bjc.6602868">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7047 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2361517">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d68666e7056 class=n-a></a>Hassan MM, Bondy ML, Wolff RA, <i> et al.</i>: Risk factors for pancreatic cancer: case-control study. <i>Am J Gastroenterol.</i> 2007; <b>102</b>(12): 2696–707. <a target=xrefwindow id=d68666e7067 href="http://www.ncbi.nlm.nih.gov/pubmed/17764494">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7070 href="http://dx.doi.org/10.1111/j.1572-0241.2007.01510.x">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2423805">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d68666e7083 class=n-a></a>Gullo L, Tomassetti P, Migliori M, <i> et al.</i>: Do early symptoms of pancreatic cancer exist that can allow an earlier diagnosis? <i>Pancreas.</i> 2001; <b>22</b>(2): 210–3. <a target=xrefwindow id=d68666e7094 href="http://www.ncbi.nlm.nih.gov/pubmed/11249079">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7097 href="http://dx.doi.org/10.1097/00006676-200103000-00017">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d68666e7106 class=n-a></a>Ferlay JS, Bray F, Forman D, <i> et al.</i>: GLOBOCAN 2008 v2.0. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010. accessed on 03/08/2013. 2008. <a target=xrefwindow id=d68666e7111 href="http://globocan.iarc.fr">Reference Source</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d68666e7121 class=n-a></a>Shaib Y, El-Serag HB: The epidemiology of cholangiocarcinoma. <i>Semin Liver Dis.</i> 2004; <b>24</b>(2): 115–25. <a target=xrefwindow id=d68666e7129 href="http://www.ncbi.nlm.nih.gov/pubmed/15192785">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7132 href="http://dx.doi.org/10.1055/s-2004-828889">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d68666e7141 class=n-a></a>Claessen MM, Vleggaar FP, Tytgat KM, <i> et al.</i>: High lifetime risk of cancer in primary sclerosing cholangitis. <i>J Hepatol.</i> 2009; <b>50</b>(1): 158–64. <a target=xrefwindow id=d68666e7152 href="http://www.ncbi.nlm.nih.gov/pubmed/19012991">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7155 href="http://dx.doi.org/10.1016/j.jhep.2008.08.013">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d68666e7164 class=n-a></a>Tyson GL, El-Serag HB: Risk factors for cholangiocarcinoma. <i>Hepatology.</i> 2011; <b>54</b>(1): 173–84. <a target=xrefwindow id=d68666e7172 href="http://www.ncbi.nlm.nih.gov/pubmed/21488076">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7175 href="http://dx.doi.org/10.1002/hep.24351">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7178 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3125451">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d68666e7187 class=n-a></a>Chapman RW: Risk factors for biliary tract carcinogenesis. <i>Ann Oncol.</i> 1999; <b>10</b>(Suppl 4): 308–11. <a target=xrefwindow id=d68666e7195 href="http://www.ncbi.nlm.nih.gov/pubmed/10436847">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7198 href="http://dx.doi.org/10.1093/annonc/10.suppl_4.S308">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d68666e7207 class=n-a></a>de Groen PC, Gores GJ, LaRusso NF, <i> et al.</i>: Biliary tract cancers. <i>N Engl J Med.</i> 1999; <b>341</b>(18): 1368–78. <a target=xrefwindow id=d68666e7218 href="http://www.ncbi.nlm.nih.gov/pubmed/10536130">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7221 href="http://dx.doi.org/10.1056/NEJM199910283411807">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d68666e7230 class=n-a></a>Saluja SS, Sharma R, Pal S, <i> et al.</i>: Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. <i>HPB (Oxford).</i> 2007; <b>9</b>(5): 373–82. <a target=xrefwindow id=d68666e7241 href="http://www.ncbi.nlm.nih.gov/pubmed/18345322">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7244 href="http://dx.doi.org/10.1080/13651820701504207">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7248 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2225516">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d68666e7258 class=n-a></a>Fernández-Esparrach G, Ginès A, Sánchez M, <i> et al.</i>: Comparison of endoscopic ultrasonography and magnetic resonance cholangiopancreatography in the diagnosis of pancreatobiliary diseases: a prospective study. <i>Am J Gastroenterol.</i> 2007; <b>102</b>(8): 1632–9. <a target=xrefwindow id=d68666e7269 href="http://www.ncbi.nlm.nih.gov/pubmed/17521400">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7272 href="http://dx.doi.org/10.1111/j.1572-0241.2007.01333.x">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d68666e7281 class=n-a></a>Sai JK, Suyama M, Kubokawa Y, <i> et al.</i>: Early detection of extrahepatic bile-duct carcinomas in the nonicteric stage by using MRCP followed by EUS. <i>Gastrointest Endosc.</i> 2009; <b>70</b>(1): 29–36. <a target=xrefwindow id=d68666e7292 href="http://www.ncbi.nlm.nih.gov/pubmed/19286177">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7295 href="http://dx.doi.org/10.1016/j.gie.2008.10.036">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d68666e7304 class=n-a></a>Lee JY: [Multidetector-row CT of malignant biliary obstruction]. <i>Korean J Gastroenterol.</i> 2006; <b>48</b>(4): 247–55. <a target=xrefwindow id=d68666e7312 href="http://www.ncbi.nlm.nih.gov/pubmed/17060718">PubMed Abstract </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d68666e7321 class=n-a></a>Kalaitzakis E, Levy M, Kamisawa T, <i> et al.</i>: Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. <i>Clin Gastroenterol Hepatol.</i> 2011; <b>9</b>(9): 800–803.e2. <a target=xrefwindow id=d68666e7332 href="http://www.ncbi.nlm.nih.gov/pubmed/21699807">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7335 href="http://dx.doi.org/10.1016/j.cgh.2011.05.019">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3246637">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d68666e7348 class=n-a></a>De Bellis M, Sherman S, Fogel EL, <i> et al.</i>: Tissue sampling at ERCP in suspected malignant biliary strictures (Part 1). <i>Gastrointest Endosc.</i> 2002; <b>56</b>(4): 552–61. <a target=xrefwindow id=d68666e7359 href="http://www.ncbi.nlm.nih.gov/pubmed/12297773">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7362 href="http://dx.doi.org/10.1016/S0016-5107(02)70442-2">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d68666e7371 class=n-a></a>Harewood GC, Baron TH, Stadheim LM, <i> et al.</i>: Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. <i>Am J Gastroenterol.</i> 2004; <b>99</b>(8): 1464–9. <a target=xrefwindow id=d68666e7382 href="http://www.ncbi.nlm.nih.gov/pubmed/15307861">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7385 href="http://dx.doi.org/10.1111/j.1572-0241.2004.30845.x">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718075881"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7395 class=n-a></a>Moreno Luna LE, Kipp B, Halling KC, <i> et al.</i>: Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. <i>Gastroenterology.</i> 2006; <b>131</b>(4): 1064–72. <a target=xrefwindow id=d68666e7406 href="http://www.ncbi.nlm.nih.gov/pubmed/17030177">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7409 href="http://dx.doi.org/10.1053/j.gastro.2006.08.021">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7413 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1769444">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718075881">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d68666e7426 class=n-a></a>Klein AP, Lindström S, Mendelsohn JB, <i> et al.</i>: An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. <i>PLoS One.</i> 2013; <b>8</b>(9): e72311. <a target=xrefwindow id=d68666e7437 href="http://www.ncbi.nlm.nih.gov/pubmed/24058443">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7440 href="http://dx.doi.org/10.1371/journal.pone.0072311">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7444 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3772857">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d68666e7453 class=n-a></a>Ariyama J, Suyama M, Ogawa K, <i> et al.</i>: [Screening of pancreatic neoplasms and the diagnostic rate of small pancreatic neoplasms]. <i>Nihon Rinsho.</i> 1986; <b>44</b>(8): 1729–34. <a target=xrefwindow id=d68666e7464 href="http://www.ncbi.nlm.nih.gov/pubmed/3537369">PubMed Abstract </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d68666e7473 class=n-a></a>Locker GY, Hamilton S, Harris J, <i> et al.</i>: ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. <i>J Clin Oncol.</i> 2006; <b>24</b>(33): 5313–27. <a target=xrefwindow id=d68666e7484 href="http://www.ncbi.nlm.nih.gov/pubmed/17060676">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7487 href="http://dx.doi.org/10.1200/JCO.2006.08.2644">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d68666e7496 class=n-a></a>Bonney GK, Craven RA, Prasad R, <i> et al.</i>: Circulating markers of biliary malignancy: opportunities in proteomics? <i>Lancet Oncol.</i> 2008; <b>9</b>(2): 149–58. <a target=xrefwindow id=d68666e7507 href="http://www.ncbi.nlm.nih.gov/pubmed/18237849">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7510 href="http://dx.doi.org/10.1016/S1470-2045(08)70027-5">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d68666e7519 class=n-a></a>Hotakainen K, Tanner P, Alfthan H, <i> et al.</i>: Comparison of three immunoassays for CA 19-9. <i>Clin Chim Acta.</i> 2009; <b>400</b>(1–2): 123–7. <a target=xrefwindow id=d68666e7530 href="http://www.ncbi.nlm.nih.gov/pubmed/19038241">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7533 href="http://dx.doi.org/10.1016/j.cca.2008.10.033">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d68666e7543 class=n-a></a>Abi-Rached B, Neugut AI: Diagnostic and management issues in gallbladder carcinoma. <i>Oncology (Williston Park).</i> 1995; <b>9</b>(1): 19–24; discussion 24, 27, 30. <a target=xrefwindow id=d68666e7551 href="http://www.ncbi.nlm.nih.gov/pubmed/7718438">PubMed Abstract </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d68666e7560 class=n-a></a>Lazaridis KN, Gores GJ: Primary sclerosing cholangitis and cholangiocarcinoma. <i>Semin Liver Dis.</i> 2006; <b>26</b>(1): 42–51. <a target=xrefwindow id=d68666e7568 href="http://www.ncbi.nlm.nih.gov/pubmed/16496232">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7571 href="http://dx.doi.org/10.1055/s-2006-933562">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d68666e7580 class=n-a></a>Khan SA, Davidson BR, Goldin RD, <i> et al.</i>: Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. <i>Gut.</i> 2012; <b>61</b>(12): 1657–69. <a target=xrefwindow id=d68666e7591 href="http://www.ncbi.nlm.nih.gov/pubmed/22895392">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7594 href="http://dx.doi.org/10.1136/gutjnl-2011-301748">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d68666e7603 class=n-a></a>Agarwal B, Correa AM, Ho L: Survival in pancreatic carcinoma based on tumor size. <i>Pancreas.</i> 2008; <b>36</b>(1): e15–20. <a target=xrefwindow id=d68666e7611 href="http://www.ncbi.nlm.nih.gov/pubmed/18192868">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7614 href="http://dx.doi.org/10.1097/mpa.0b013e31814de421">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727775566"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7623 class=n-a></a>Malgerud L, Lindberg J, Wirta V, <i> et al.</i>: Bioinformatory-assisted analysis of next-generation sequencing data for precision medicine in pancreatic cancer. <i>Mol Oncol.</i> 2017. <a target=xrefwindow id=d68666e7631 href="http://www.ncbi.nlm.nih.gov/pubmed/28675654">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7634 href="http://dx.doi.org/10.1002/1878-0261.12108">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727775566">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727540900"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7647 class=n-a></a>Lindahl A, Heuchel R, Forshed J, <i> et al.</i>: Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics. <i>Metabolomics.</i> 2017; <b>13</b>(5): 61. <a target=xrefwindow id=d68666e7658 href="http://www.ncbi.nlm.nih.gov/pubmed/28413374">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7661 href="http://dx.doi.org/10.1007/s11306-017-1199-6">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5376388">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727540900">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717973033"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7679 class=n-a></a>Metzger J, Negm AA, Plentz RR, <i> et al.</i>: Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. <i>Gut.</i> 2013; <b>62</b>(1): 122–30. <a target=xrefwindow id=d68666e7690 href="http://www.ncbi.nlm.nih.gov/pubmed/22580416">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7693 href="http://dx.doi.org/10.1136/gutjnl-2012-302047">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717973033">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d68666e7706 class=n-a></a>Radon TP, Massat NJ, Jones R, <i> et al.</i>: Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma. <i>Clin Cancer Res.</i> 2015; <b>21</b>(15): 3512–21. <a target=xrefwindow id=d68666e7717 href="http://www.ncbi.nlm.nih.gov/pubmed/26240291">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7720 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-2467">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7724 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4539580">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d68666e7733 class=n-a></a>Holly EA, Chaliha I, Bracci PM, <i> et al.</i>: Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. <i>Clin Gastroenterol Hepatol.</i> 2004; <b>2</b>(6): 510–7. <a target=xrefwindow id=d68666e7744 href="http://www.ncbi.nlm.nih.gov/pubmed/15181621">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7747 href="http://dx.doi.org/10.1016/S1542-3565(04)00171-5">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d68666e7756 class=n-a></a>Keane MG, Bramis K, Pereira SP, <i> et al.</i>: Systematic review of novel ablative methods in locally advanced pancreatic cancer. <i>World J Gastroenterol.</i> 2014; <b>20</b>(9): 2267–78. <a target=xrefwindow id=d68666e7767 href="http://www.ncbi.nlm.nih.gov/pubmed/24605026">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7770 href="http://dx.doi.org/10.3748/wjg.v20.i9.2267">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7774 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3942832">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d68666e7783 class=n-a></a>Keane MG, Horsfall L, Rait G, <i> et al.</i>: A case-control study comparing the incidence of early symptoms in pancreatic and biliary tract cancer. <i>BMJ Open.</i> 2014; <b>4</b>(11): e005720. <a target=xrefwindow id=d68666e7794 href="http://www.ncbi.nlm.nih.gov/pubmed/25410605">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7797 href="http://dx.doi.org/10.1136/bmjopen-2014-005720">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7801 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4244441">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d68666e7810 class=n-a></a>Macmillan: Early diagnosis programme. 2014; (accessed 15th May 2014). <a target=xrefwindow id=d68666e7812 href="https://www.macmillan.org.uk/about-us/health-professionals/programmes-and-services/prevention-early-diagnosis-programme">Reference Source</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d68666e7822 class=n-a></a>Dumonceau JM, Polkowski M, Larghi A, <i> et al.</i>: Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. <i>Endoscopy.</i> 2011; <b>43</b>(10): 897–912. <a target=xrefwindow id=d68666e7833 href="http://www.ncbi.nlm.nih.gov/pubmed/21842456">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7836 href="http://dx.doi.org/10.1055/s-0030-1256754">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729086476"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7845 class=n-a></a>Jenssen C, Hocke M, Fusaroli P, <i> et al.</i>: EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part IV - EUS-guided interventions: General Aspects and EUS-guided Sampling (Short Version). <i>Ultraschall Med.</i> 2016; <b>37</b>(2): 157–69. <a target=xrefwindow id=d68666e7856 href="http://www.ncbi.nlm.nih.gov/pubmed/27058434">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7859 href="http://dx.doi.org/10.1055/s-0035-1553788">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729086476">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718075883"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7872 class=n-a></a>Mohamadnejad M, DeWitt JM, Sherman S, <i> et al.</i>: Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. <i>Gastrointest Endosc.</i> 2011; <b>73</b>(1): 71–8. <a target=xrefwindow id=d68666e7883 href="http://www.ncbi.nlm.nih.gov/pubmed/21067747">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7886 href="http://dx.doi.org/10.1016/j.gie.2010.08.050">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718075883">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d68666e7899 class=n-a></a>Fuccio L, Hassan C, Laterza L, <i> et al.</i>: The role of K-<i>ras</i> gene mutation analysis in EUS-guided FNA cytology specimens for the differential diagnosis of pancreatic solid masses: a meta-analysis of prospective studies. <i>Gastrointest Endosc.</i> 2013; <b>78</b>(4): 596–608. <a target=xrefwindow id=d68666e7913 href="http://www.ncbi.nlm.nih.gov/pubmed/23660563">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7917 href="http://dx.doi.org/10.1016/j.gie.2013.04.162">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726282564"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e7926 class=n-a></a>Wang J, Wu X, Yin P, <i> et al.</i>: Comparing endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) versus fine needle biopsy (FNB) in the diagnosis of solid lesions: study protocol for a randomized controlled trial. <i>Trials.</i> 2016; <b>17</b>: 198. <a target=xrefwindow id=d68666e7937 href="http://www.ncbi.nlm.nih.gov/pubmed/27071386">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7940 href="http://dx.doi.org/10.1186/s13063-016-1316-2">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7944 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4830051">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726282564">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d68666e7957 class=n-a></a>Klapman JB, Logrono R, Dye CE, <i> et al.</i>: Clinical impact of on-site cytopathology interpretation on endoscopic ultrasound-guided fine needle aspiration. <i>Am J Gastroenterol.</i> 2003; <b>98</b>(6): 1289–94. <a target=xrefwindow id=d68666e7968 href="http://www.ncbi.nlm.nih.gov/pubmed/12818271">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7971 href="http://dx.doi.org/10.1111/j.1572-0241.2003.07472.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d68666e7981 class=n-a></a>van Riet PA, Cahen DL, Poley JW, <i> et al.</i>: Mapping international practice patterns in EUS-guided tissue sampling: outcome of a global survey. <i>Endosc Int Open.</i> 2016; <b>4</b>(3): E360–70. <a target=xrefwindow id=d68666e7992 href="http://www.ncbi.nlm.nih.gov/pubmed/27227103">PubMed Abstract </a> | <a target=xrefwindow id=d68666e7995 href="http://dx.doi.org/10.1055/s-0042-101023">Publisher Full Text </a> | <a target=xrefwindow id=d68666e7999 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4873668">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d68666e8008 class=n-a></a>Wani S, Mullady D, Early DS, <i> et al.</i>: The clinical impact of immediate on-site cytopathology evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: a prospective multicenter randomized controlled trial. <i>Am J Gastroenterol.</i> 2015; <b>110</b>(10): 1429–39. <a target=xrefwindow id=d68666e8019 href="http://www.ncbi.nlm.nih.gov/pubmed/26346868">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8022 href="http://dx.doi.org/10.1038/ajg.2015.262">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d68666e8031 class=n-a></a>Dawwas MF, Taha H, Leeds JS, <i> et al.</i>: Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study. <i>Gastrointest Endosc.</i> 2012; <b>76</b>(5): 953–61. <a target=xrefwindow id=d68666e8042 href="http://www.ncbi.nlm.nih.gov/pubmed/22854060">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8045 href="http://dx.doi.org/10.1016/j.gie.2012.05.034">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d68666e8054 class=n-a></a>Soares JB, Iglesias-Garcia J, Goncalves B, <i> et al.</i>: Interobserver agreement of EUS elastography in the evaluation of solid pancreatic lesions. <i>Endosc Ultrasound.</i> 2015; <b>4</b>(3): 244–9. <a target=xrefwindow id=d68666e8065 href="http://www.ncbi.nlm.nih.gov/pubmed/26374584">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8068 href="http://dx.doi.org/10.4103/2303-9027.163016">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8072 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4568638">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d68666e8081 class=n-a></a>Fusaroli P, Kypraios D, Mancino MG, <i> et al.</i>: Interobserver agreement in contrast harmonic endoscopic ultrasound. <i>J Gastroenterol Hepatol.</i> 2012; <b>27</b>(6): 1063–9. <a target=xrefwindow id=d68666e8092 href="http://www.ncbi.nlm.nih.gov/pubmed/22414180">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8095 href="http://dx.doi.org/10.1111/j.1440-1746.2012.07115.x">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729086477"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8104 class=n-a></a>Iglesias-Garcia J, Lindkvist B, Lariño-Noia J, <i> et al.</i>: Differential diagnosis of solid pancreatic masses: contrast-enhanced harmonic (CEH-EUS), quantitative-elastography (QE-EUS), or both? <i>United European Gastroenterol J.</i> 2017; <b>5</b>(2): 236–46. <a target=xrefwindow id=d68666e8115 href="http://www.ncbi.nlm.nih.gov/pubmed/28344791">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8118 href="http://dx.doi.org/10.1177/2050640616640635">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8122 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5349356">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729086477">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d68666e8136 class=n-a></a>Dietrich CF: Contrast-enhanced low mechanical index endoscopic ultrasound (CELMI-EUS). <i>Endoscopy.</i> 2009; <b>41</b>(Suppl 2): E43–4. <a target=xrefwindow id=d68666e8144 href="http://www.ncbi.nlm.nih.gov/pubmed/19288418">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8147 href="http://dx.doi.org/10.1055/s-0028-1119491">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d68666e8156 class=n-a></a>Dietrich CF, Braden B, Hocke M, <i> et al.</i>: Improved characterisation of solitary solid pancreatic tumours using contrast enhanced transabdominal ultrasound. <i>J Cancer Res Clin Oncol.</i> 2008; <b>134</b>(6): 635–43. <a target=xrefwindow id=d68666e8167 href="http://www.ncbi.nlm.nih.gov/pubmed/17952469">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8170 href="http://dx.doi.org/10.1007/s00432-007-0326-6">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726949390"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8179 class=n-a></a>Dietrich CF, Dong Y, Froehlich E, <i> et al.</i>: Dynamic contrast-enhanced endoscopic ultrasound: A quantification method. <i>Endosc Ultrasound.</i> 2017; <b>6</b>(1): 12–20. <a target=xrefwindow id=d68666e8190 href="http://www.ncbi.nlm.nih.gov/pubmed/28218195">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8193 href="http://dx.doi.org/10.4103/2303-9027.193595">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8197 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5331837">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726949390">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d68666e8210 class=n-a></a>Fusaroli P, Kypreos D, Alma Petrini CA, <i> et al.</i>: Scientific publications in endoscopic ultrasonography: changing trends in the third millennium. <i>J Clin Gastroenterol.</i> 2011; <b>45</b>(5): 400–4. <a target=xrefwindow id=d68666e8221 href="http://www.ncbi.nlm.nih.gov/pubmed/21063209">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8224 href="http://dx.doi.org/10.1097/MCG.0b013e3181fbde42">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d68666e8233 class=n-a></a>Giovannini M, Thomas B, Erwan B, <i> et al.</i>: Endoscopic ultrasound elastography for evaluation of lymph nodes and pancreatic masses: a multicenter study. <i>World J Gastroenterol.</i> 2009; <b>15</b>(13): 1587–93. <a target=xrefwindow id=d68666e8244 href="http://www.ncbi.nlm.nih.gov/pubmed/19340900">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8247 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2669942">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d68666e8256 class=n-a></a>Karstensen J, Cartana T, Pia K, <i> et al.</i>: Endoscopic ultrasound-guided needle confocal laser endomicroscopy in pancreatic masses. <i>Endosc Ultrasound.</i> 2014; <b>3</b>(Suppl 1): S2–3. <a target=xrefwindow id=d68666e8267 href="http://www.ncbi.nlm.nih.gov/pubmed/26425525">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8270 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4569925">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d68666e8280 class=n-a></a>de Bellis M, Sherman S, Fogel EL, <i> et al.</i>: Tissue sampling at ERCP in suspected malignant biliary strictures (Part 2). <i>Gastrointest Endosc.</i> 2002; <b>56</b>(5): 720–30. <a target=xrefwindow id=d68666e8291 href="http://www.ncbi.nlm.nih.gov/pubmed/12397282">PubMed Abstract </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d68666e8300 class=n-a></a>Baron TH, Harewood GC, Rumalla A, <i> et al.</i>: A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. <i>Clin Gastroenterol Hepatol.</i> 2004; <b>2</b>(3): 214–9. <a target=xrefwindow id=d68666e8311 href="http://www.ncbi.nlm.nih.gov/pubmed/15017605">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8314 href="http://dx.doi.org/10.1016/S1542-3565(04)00006-0">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d68666e8323 class=n-a></a>Bergquist A, Tribukait B, Glaumann H, <i> et al.</i>: Can DNA cytometry be used for evaluation of malignancy and premalignancy in bile duct strictures in primary sclerosing cholangitis? <i>J Hepatol.</i> 2000; <b>33</b>(6): 873–7. <a target=xrefwindow id=d68666e8334 href="http://www.ncbi.nlm.nih.gov/pubmed/11131447">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8337 href="http://dx.doi.org/10.1016/S0168-8278(00)80117-8">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718075882"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8346 class=n-a></a>Bangarulingam SY, Bjornsson E, Enders F, <i> et al.</i>: Long-term outcomes of positive fluorescence <i>in situ</i> hybridization tests in primary sclerosing cholangitis. <i>Hepatology.</i> 2010; <b>51</b>(1): 174–80. <a target=xrefwindow id=d68666e8360 href="http://www.ncbi.nlm.nih.gov/pubmed/19877179">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8364 href="http://dx.doi.org/10.1002/hep.23277">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718075882">F1000 Recommendation</a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d68666e8377 class=n-a></a>Tischendorf JJ, Krüger M, Trautwein C, <i> et al.</i>: Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. <i>Endoscopy.</i> 2006; <b>38</b>(7): 665–9. <a target=xrefwindow id=d68666e8388 href="http://www.ncbi.nlm.nih.gov/pubmed/16673310">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8391 href="http://dx.doi.org/10.1055/s-2006-925257">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d68666e8400 class=n-a></a>Navaneethan U, Hasan MK, Lourdusamy V, <i> et al.</i>: Single-operator cholangioscopy and targeted biopsies in the diagnosis of indeterminate biliary strictures: a systematic review. <i>Gastrointest Endosc.</i> 2015; <b>82</b>(4): 608–14.e2. <a target=xrefwindow id=d68666e8411 href="http://www.ncbi.nlm.nih.gov/pubmed/26071061">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8414 href="http://dx.doi.org/10.1016/j.gie.2015.04.030">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8418 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4826032">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d68666e8428 class=n-a></a>Chen YK, Parsi MA, Binmoeller KF, <i> et al.</i>: Single-operator cholangioscopy in patients requiring evaluation of bile duct disease or therapy of biliary stones (with videos). <i>Gastrointest Endosc.</i> 2011; <b>74</b>(4): 805–14. <a target=xrefwindow id=d68666e8439 href="http://www.ncbi.nlm.nih.gov/pubmed/21762903">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8442 href="http://dx.doi.org/10.1016/j.gie.2011.04.016">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718075885"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8451 class=n-a></a>Larghi A, Waxman I: Endoscopic direct cholangioscopy by using an ultra-slim upper endoscope: a feasibility study. <i>Gastrointest Endosc.</i> 2006; <b>63</b>(6): 853–7. <a target=xrefwindow id=d68666e8459 href="http://www.ncbi.nlm.nih.gov/pubmed/16650553">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8462 href="http://dx.doi.org/10.1016/j.gie.2005.07.050">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718075885">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d68666e8475 class=n-a></a>Hoffman A, Kiesslich R, Bittinger F, <i> et al.</i>: Methylene blue-aided cholangioscopy in patients with biliary strictures: feasibility and outcome analysis. <i>Endoscopy.</i> 2008; <b>40</b>(7): 563–71. <a target=xrefwindow id=d68666e8486 href="http://www.ncbi.nlm.nih.gov/pubmed/18404601">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8489 href="http://dx.doi.org/10.1055/s-2007-995688">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d68666e8498 class=n-a></a>Hoffman A, Kiesslich R, Moench C, <i> et al.</i>: Methylene blue-aided cholangioscopy unravels the endoscopic features of ischemic-type biliary lesions after liver transplantation. <i>Gastrointest Endosc.</i> 2007; <b>66</b>(5): 1052–8. <a target=xrefwindow id=d68666e8509 href="http://www.ncbi.nlm.nih.gov/pubmed/17963894">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8512 href="http://dx.doi.org/10.1016/j.gie.2007.04.022">Publisher Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d68666e8521 class=n-a></a>Itoi T, Sofuni A, Itokawa F, <i> et al.</i>: Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). <i>Gastrointest Endosc.</i> 2007; <b>66</b>(4): 730–6. <a target=xrefwindow id=d68666e8532 href="http://www.ncbi.nlm.nih.gov/pubmed/17905015">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8535 href="http://dx.doi.org/10.1016/j.gie.2007.02.056">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d68666e8544 class=n-a></a>Lu X, Itoi T, Kubota K: Cholangioscopy by using narrow-band imaging and transpapillary radiotherapy for mucin-producing bile duct tumor. <i>Clin Gastroenterol Hepatol.</i> 2009; <b>7</b>(6): e34–5. <a target=xrefwindow id=d68666e8552 href="http://www.ncbi.nlm.nih.gov/pubmed/19061973">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8555 href="http://dx.doi.org/10.1016/j.cgh.2008.11.001">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d68666e8565 class=n-a></a>Itoi T, Neuhaus H, Chen YK: Diagnostic value of image-enhanced video cholangiopancreatoscopy. <i>Gastrointest Endosc Clin N Am.</i> 2009; <b>19</b>(4): 557–66. <a target=xrefwindow id=d68666e8573 href="http://www.ncbi.nlm.nih.gov/pubmed/19917461">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8576 href="http://dx.doi.org/10.1016/j.giec.2009.06.002">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d68666e8585 class=n-a></a>Meining A, Frimberger E, Becker V, <i> et al.</i>: Detection of cholangiocarcinoma <i>in vivo</i> using miniprobe-based confocal fluorescence microscopy. <i>Clin Gastroenterol Hepatol.</i> 2008; <b>6</b>(9): 1057–60. <a target=xrefwindow id=d68666e8599 href="http://www.ncbi.nlm.nih.gov/pubmed/18639496">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8603 href="http://dx.doi.org/10.1016/j.cgh.2008.04.014">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d68666e8612 class=n-a></a>Giovannini M, Bories E, Monges G, <i> et al.</i>: Results of a phase I-II study on intraductal confocal microscopy (IDCM) in patients with common bile duct (CBD) stenosis. <i>Surg Endosc.</i> 2011; <b>25</b>(7): 2247–53. <a target=xrefwindow id=d68666e8623 href="http://www.ncbi.nlm.nih.gov/pubmed/21424206">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8626 href="http://dx.doi.org/10.1007/s00464-010-1542-8">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d68666e8635 class=n-a></a>Slivka A, Gan I, Jamidar P, <i> et al.</i>: Validation of the diagnostic accuracy of probe-based confocal laser endomicroscopy for the characterization of indeterminate biliary strictures: results of a prospective multicenter international study. <i>Gastrointest Endosc.</i> 2015; <b>81</b>(2): 282–90. <a target=xrefwindow id=d68666e8646 href="http://www.ncbi.nlm.nih.gov/pubmed/25616752">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8649 href="http://dx.doi.org/10.1016/j.gie.2014.10.009">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d68666e8658 class=n-a></a>Meining A, Phillip V, Gaa J, <i> et al.</i>: Pancreaticoscopy with miniprobe-based confocal laser-scanning microscopy of an intraductal papillary mucinous neoplasm (with video). <i>Gastrointest Endosc.</i> 2009; <b>69</b>(6): 1178–80. <a target=xrefwindow id=d68666e8669 href="http://www.ncbi.nlm.nih.gov/pubmed/19152895">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8672 href="http://dx.doi.org/10.1016/j.gie.2008.06.013">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718075884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8681 class=n-a></a>Menzel J, Poremba C, Dietl KH, <i> et al.</i>: Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography. <i>Scand J Gastroenterol.</i> 2000; <b>35</b>(1): 77–82. <a target=xrefwindow id=d68666e8692 href="http://www.ncbi.nlm.nih.gov/pubmed/10672839">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8695 href="http://dx.doi.org/10.1080/003655200750024579">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718075884">F1000 Recommendation</a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d68666e8709 class=n-a></a>Han Y, Zhang W, Liu Y: Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma. <i>World J Surg.</i> 2013; <b>37</b>(10): 2419–27. <a target=xrefwindow id=d68666e8717 href="http://www.ncbi.nlm.nih.gov/pubmed/23793608">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8720 href="http://dx.doi.org/10.1007/s00268-013-2132-4">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d68666e8729 class=n-a></a>Ruzzenente A, Iacono C, Conci S, <i> et al.</i>: A novel serum marker for biliary tract cancer: diagnostic and prognostic values of quantitative evaluation of serum mucin 5AC (MUC5AC). <i>Surgery.</i> 2014; <b>155</b>(4): 633–9. <a target=xrefwindow id=d68666e8740 href="http://www.ncbi.nlm.nih.gov/pubmed/24468034">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8743 href="http://dx.doi.org/10.1016/j.surg.2013.12.003">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d68666e8752 class=n-a></a>Voigtländer T, David S, Thamm K, <i> et al.</i>: Angiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma. <i>PLoS One.</i> 2014; <b>9</b>(5): e97046. <a target=xrefwindow id=d68666e8763 href="http://www.ncbi.nlm.nih.gov/pubmed/24823366">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8766 href="http://dx.doi.org/10.1371/journal.pone.0097046">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8770 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4019663">Free Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d68666e8779 class=n-a></a>Lumachi F, Lo Re G, Tozzoli R, <i> et al.</i>: Measurement of serum carcinoembryonic antigen, carbohydrate antigen 19-9, cytokeratin-19 fragment and matrix metalloproteinase-7 for detecting cholangiocarcinoma: a preliminary case-control study. <i>Anticancer Res.</i> 2014; <b>34</b>(11): 6663–7. <a target=xrefwindow id=d68666e8790 href="http://www.ncbi.nlm.nih.gov/pubmed/25368272">PubMed Abstract </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d68666e8799 class=n-a></a>Wang YF, Feng FL, Zhao XH, <i> et al.</i>: Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. <i>World J Gastroenterol.</i> 2014; <b>20</b>(14): 4085–92. <a target=xrefwindow id=d68666e8810 href="http://www.ncbi.nlm.nih.gov/pubmed/24744600">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8813 href="http://dx.doi.org/10.3748/wjg.v20.i14.4085">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8817 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3983467">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d68666e8826 class=n-a></a>Liu MC, Jiang L, Hong HJ, <i> et al.</i>: Serum vascular endothelial growth factors C and D as forecast tools for patients with gallbladder carcinoma. <i>Tumour Biol.</i> 2015; <b>36</b>(8): 6305–12. <a target=xrefwindow id=d68666e8837 href="http://www.ncbi.nlm.nih.gov/pubmed/25801241">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8840 href="http://dx.doi.org/10.1007/s13277-015-3316-3">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8844 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4546698">Free Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d68666e8854 class=n-a></a>Huang L, Chen W, Liang P, <i> et al.</i>: Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma. <i>Dig Dis Sci.</i> 2015; <b>60</b>(5): 1273–83. <a target=xrefwindow id=d68666e8865 href="http://www.ncbi.nlm.nih.gov/pubmed/25487191">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8868 href="http://dx.doi.org/10.1007/s10620-014-3472-0">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d68666e8877 class=n-a></a>Nigam J, Chandra A, Kazmi HR, <i> et al.</i>: Expression of serum survivin protein in diagnosis and prognosis of gallbladder cancer: a comparative study. <i>Med Oncol.</i> 2014; <b>31</b>(9): 167. <a target=xrefwindow id=d68666e8888 href="http://www.ncbi.nlm.nih.gov/pubmed/25129311">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8891 href="http://dx.doi.org/10.1007/s12032-014-0167-5">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d68666e8900 class=n-a></a>Rucksaken R, Pairojkul C, Pinlaor P, <i> et al.</i>: Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma. <i>PLoS One.</i> 2014; <b>9</b>(7): e103259. <a target=xrefwindow id=d68666e8911 href="http://www.ncbi.nlm.nih.gov/pubmed/25058392">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8914 href="http://dx.doi.org/10.1371/journal.pone.0103259">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8918 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4109983">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d68666e8927 class=n-a></a>Ince AT, Yildiz K, Baysal B, <i> et al.</i>: Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions. <i>Turk J Gastroenterol.</i> 2014; <b>25</b>(2): 162–9. <a target=xrefwindow id=d68666e8938 href="http://www.ncbi.nlm.nih.gov/pubmed/25003676">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8941 href="http://dx.doi.org/10.5152/tjg.2014.6056">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729086478"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8950 class=n-a></a>Rucksaken R, Charoensuk L, Pinlaor P, <i> et al.</i>: Plasma orosomucoid 2 as a potential risk marker of cholangiocarcinoma. <i>Cancer Biomark.</i> 2017; <b>18</b>(1): 27–34. <a target=xrefwindow id=d68666e8961 href="http://www.ncbi.nlm.nih.gov/pubmed/27814272">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8964 href="http://dx.doi.org/10.3233/CBM-160670">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729086478">F1000 Recommendation</a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726216524"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e8977 class=n-a></a>Rose JB, Correa-Gallego C, Li Y, <i> et al.</i>: The Role of Biliary Carcinoembryonic Antigen-Related Cellular Adhesion Molecule 6 (CEACAM6) as a Biomarker in Cholangiocarcinoma. <i>PLoS One.</i> 2016; <b>11</b>(3): e0150195. <a target=xrefwindow id=d68666e8988 href="http://www.ncbi.nlm.nih.gov/pubmed/26974538">PubMed Abstract </a> | <a target=xrefwindow id=d68666e8991 href="http://dx.doi.org/10.1371/journal.pone.0150195">Publisher Full Text </a> | <a target=xrefwindow id=d68666e8995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4790932">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726216524">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d68666e9009 class=n-a></a>Jiao X, Mo Y, Wu Y, <i> et al.</i>: Upregulated plasma and urinary levels of nucleosides as biological markers in the diagnosis of primary gallbladder cancer. <i>J Sep Sci.</i> 2014; <b>37</b>(21): 3033–44. <a target=xrefwindow id=d68666e9020 href="http://www.ncbi.nlm.nih.gov/pubmed/25137411">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9023 href="http://dx.doi.org/10.1002/jssc.201400638">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726765138"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9032 class=n-a></a>Sogawa K, Takano S, Iida F, <i> et al.</i>: Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. <i>Br J Cancer.</i> 2016; <b>115</b>(8): 949–56. <a target=xrefwindow id=d68666e9043 href="http://www.ncbi.nlm.nih.gov/pubmed/27657339">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9046 href="http://dx.doi.org/10.1038/bjc.2016.295">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9050 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5061912">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726765138">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d68666e9063 class=n-a></a>Rychlíková J, Vecka M, Jáchymová M: Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. <i>Cancer Biomark.</i> 2016; <b>17</b>(1): 55–65. <a target=xrefwindow id=d68666e9071 href="http://www.ncbi.nlm.nih.gov/pubmed/27314293">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9074 href="http://dx.doi.org/10.3233/CBM-160617">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726620617"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9083 class=n-a></a>Lin C, Wu WC, Zhao GC, <i> et al.</i>: ITRAQ-based quantitative proteomics reveals apolipoprotein A-I and transferrin as potential serum markers in CA19-9 negative pancreatic ductal adenocarcinoma. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(31): e4527. <a target=xrefwindow id=d68666e9094 href="http://www.ncbi.nlm.nih.gov/pubmed/27495108">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9097 href="http://dx.doi.org/10.1097/MD.0000000000004527">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4979862">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726620617">F1000 Recommendation</a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726411117"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9114 class=n-a></a>Guo X, Lv X, Fang C, <i> et al.</i>: Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. <i>Int J Cancer.</i> 2016; <b>139</b>(8): 1821–9. <a target=xrefwindow id=d68666e9125 href="http://www.ncbi.nlm.nih.gov/pubmed/27281120">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9128 href="http://dx.doi.org/10.1002/ijc.30227">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726411117">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d68666e9141 class=n-a></a>Han SX, Zhou X, Sui X, <i> et al.</i>: Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. <i>Oncotarget.</i> 2015; <b>6</b>(23): 19907–17. <a target=xrefwindow id=d68666e9152 href="http://www.ncbi.nlm.nih.gov/pubmed/26101916">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9155 href="http://dx.doi.org/10.18632/oncotarget.4529">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4637329">Free Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d68666e9169 class=n-a></a>Qu D, Johnson J, Chandrakesan P, <i> et al.</i>: Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. <i>PLoS One.</i> 2015; <b>10</b>(2): e0118933. <a target=xrefwindow id=d68666e9180 href="http://www.ncbi.nlm.nih.gov/pubmed/25723399">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9183 href="http://dx.doi.org/10.1371/journal.pone.0118933">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9187 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4344195">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a name=d68666e9196 class=n-a></a>Dong H, Qian D, Wang Y, <i> et al.</i>: Survivin expression and serum levels in pancreatic cancer. <i>World J Surg Oncol.</i> 2015; <b>13</b>: 189. <a target=xrefwindow id=d68666e9207 href="http://www.ncbi.nlm.nih.gov/pubmed/26016480">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9210 href="http://dx.doi.org/10.1186/s12957-015-0605-7">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9214 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4469100">Free Full Text </a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a name=d68666e9223 class=n-a></a>Gebauer F, Struck L, Tachezy M, <i> et al.</i>: Serum EpCAM expression in pancreatic cancer. <i>Anticancer Res.</i> 2014; <b>34</b>(9): 4741–6. <a target=xrefwindow id=d68666e9234 href="http://www.ncbi.nlm.nih.gov/pubmed/25202052">PubMed Abstract </a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d68666e9243 class=n-a></a>Wang X, Li Y, Tian H, <i> et al.</i>: Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma. <i>BMC Cancer.</i> 2014; <b>14</b>: 578. <a target=xrefwindow id=d68666e9254 href="http://www.ncbi.nlm.nih.gov/pubmed/25106741">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9257 href="http://dx.doi.org/10.1186/1471-2407-14-578">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9261 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4133074">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d68666e9270 class=n-a></a>Kendrick ZW, Firpo MA, Repko RC, <i> et al.</i>: Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer. <i>HPB (Oxford).</i> 2014; <b>16</b>(7): 670–6. <a target=xrefwindow id=d68666e9281 href="http://www.ncbi.nlm.nih.gov/pubmed/24308545">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9284 href="http://dx.doi.org/10.1111/hpb.12199">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4105906">Free Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d68666e9297 class=n-a></a>Kang CY, Wang J, Axell-House D, <i> et al.</i>: Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma. <i>J Gastrointest Surg.</i> 2014; <b>18</b>(1): 7–15. <a target=xrefwindow id=d68666e9308 href="http://www.ncbi.nlm.nih.gov/pubmed/24002763">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9311 href="http://dx.doi.org/10.1007/s11605-013-2326-y">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d68666e9321 class=n-a></a>Willumsen N, Bager CL, Leeming DJ, <i> et al.</i>: Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls. <i>BMC Cancer.</i> 2013; <b>13</b>: 554. <a target=xrefwindow id=d68666e9332 href="http://www.ncbi.nlm.nih.gov/pubmed/24261855">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9335 href="http://dx.doi.org/10.1186/1471-2407-13-554">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9339 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4222497">Free Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d68666e9348 class=n-a></a>Falco A, Rosati A, Festa M, <i> et al.</i>: BAG3 is a novel serum biomarker for pancreatic adenocarcinomas. <i>Am J Gastroenterol.</i> 2013; <b>108</b>(7): 1178–80. <a target=xrefwindow id=d68666e9359 href="http://www.ncbi.nlm.nih.gov/pubmed/23821002">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9362 href="http://dx.doi.org/10.1038/ajg.2013.128">Publisher Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d68666e9371 class=n-a></a>Chen J, Chen LJ, Xia YL, <i> et al.</i>: Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma. <i>J Cancer Res Clin Oncol.</i> 2013; <b>139</b>(7): 1117–27. <a target=xrefwindow id=d68666e9382 href="http://www.ncbi.nlm.nih.gov/pubmed/23546595">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9385 href="http://dx.doi.org/10.1007/s00432-013-1422-4">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d68666e9394 class=n-a></a>Gold DV, Gaedcke J, Ghadimi BM, <i> et al.</i>: PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma. <i>Cancer.</i> 2013; <b>119</b>(3): 522–8. <a target=xrefwindow id=d68666e9405 href="http://www.ncbi.nlm.nih.gov/pubmed/22898932">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9408 href="http://dx.doi.org/10.1002/cncr.27762">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9412 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3502643">Free Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d68666e9421 class=n-a></a>Poruk KE, Firpo MA, Scaife CL, <i> et al.</i>: Serum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma. <i>Pancreas.</i> 2013; <b>42</b>(2): 193–7. <a target=xrefwindow id=d68666e9432 href="http://www.ncbi.nlm.nih.gov/pubmed/23407481">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9435 href="http://dx.doi.org/10.1097/MPA.0b013e31825e354d">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9439 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3576824">Free Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d68666e9448 class=n-a></a>Lee MJ, Na K, Jeong SK, <i> et al.</i>: Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma. <i>J Proteome Res.</i> 2014; <b>13</b>(11): 4878–88. <a target=xrefwindow id=d68666e9459 href="http://www.ncbi.nlm.nih.gov/pubmed/25057901">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9462 href="http://dx.doi.org/10.1021/pr5002719">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726227071"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9472 class=n-a></a>Abdel-Razik A, ElMahdy Y, Hanafy EE, <i> et al.</i>: Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions. <i>Am J Med Sci.</i> 2016; <b>351</b>(3): 259–64. <a target=xrefwindow id=d68666e9483 href="http://www.ncbi.nlm.nih.gov/pubmed/26992254">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9486 href="http://dx.doi.org/10.1016/j.amjms.2015.12.013">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726227071">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a name=d68666e9499 class=n-a></a>Makawita S, Dimitromanolakis A, Soosaipillai A, <i> et al.</i>: Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. <i>BMC Cancer.</i> 2013; <b>13</b>: 404. <a target=xrefwindow id=d68666e9510 href="http://www.ncbi.nlm.nih.gov/pubmed/24007603">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9513 href="http://dx.doi.org/10.1186/1471-2407-13-404">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9517 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3847832">Free Full Text </a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d68666e9526 class=n-a></a>Shaw VE, Lane B, Jenkinson C, <i> et al.</i>: Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. <i>Mol Cancer.</i> 2014; <b>13</b>: 114. <a target=xrefwindow id=d68666e9537 href="http://www.ncbi.nlm.nih.gov/pubmed/24884871">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9540 href="http://dx.doi.org/10.1186/1476-4598-13-114">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9544 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4032456">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d68666e9553 class=n-a></a>Brand RE, Nolen BM, Zeh HJ, <i> et al.</i>: Serum biomarker panels for the detection of pancreatic cancer. <i>Clin Cancer Res.</i> 2011; <b>17</b>(4): 805–16. <a target=xrefwindow id=d68666e9564 href="http://www.ncbi.nlm.nih.gov/pubmed/21325298">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9567 href="http://dx.doi.org/10.1158/1078-0432.CCR-10-0248">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9571 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3075824">Free Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727117187"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9580 class=n-a></a>Capello M, Bantis LE, Scelo G, <i> et al.</i>: Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. <i>J Natl Cancer Inst.</i> 2017; <b>109</b>(4): djw266. <a target=xrefwindow id=d68666e9591 href="http://www.ncbi.nlm.nih.gov/pubmed/28376157">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9594 href="http://dx.doi.org/10.1093/jnci/djw266">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9598 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5441297">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727117187">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d68666e9611 class=n-a></a>Chan A, Prassas I, Dimitromanolakis A, <i> et al.</i>: Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer. <i>Clin Cancer Res.</i> 2014; <b>20</b>(22): 5787–95. <a target=xrefwindow id=d68666e9622 href="http://www.ncbi.nlm.nih.gov/pubmed/25239611">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9625 href="http://dx.doi.org/10.1158/1078-0432.CCR-14-0289">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9629 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4233184">Free Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726422092"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9639 class=n-a></a>Ankeny JS, Court CM, Hou S, <i> et al.</i>: Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. <i>Br J Cancer.</i> 2016; <b>114</b>(12): 1367–75. <a target=xrefwindow id=d68666e9650 href="http://www.ncbi.nlm.nih.gov/pubmed/27300108">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9653 href="http://dx.doi.org/10.1038/bjc.2016.121">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9657 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4984454">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726422092">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726036462"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9670 class=n-a></a>Kulemann B, Liss AS, Warshaw AL, <i> et al.</i>: KRAS mutations in pancreatic circulating tumor cells: a pilot study. <i>Tumour Biol.</i> 2016; <b>37</b>(6): 7547–54. <a target=xrefwindow id=d68666e9681 href="http://www.ncbi.nlm.nih.gov/pubmed/26684803">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9684 href="http://dx.doi.org/10.1007/s13277-015-4589-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726036462">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d68666e9697 class=n-a></a>Singh N, Gupta S, Pandey RM, <i> et al.</i>: High levels of cell-free circulating nucleic acids in pancreatic cancer are associated with vascular encasement, metastasis and poor survival. <i>Cancer Invest.</i> 2015; <b>33</b>(3): 78–85. <a target=xrefwindow id=d68666e9708 href="http://www.ncbi.nlm.nih.gov/pubmed/25647443">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9711 href="http://dx.doi.org/10.3109/07357907.2014.1001894">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d68666e9720 class=n-a></a>Kinugasa H, Nouso K, Miyahara K, <i> et al.</i>: Detection of <i>K-ras</i> gene mutation by liquid biopsy in patients with pancreatic cancer. <i>Cancer.</i> 2015; <b>121</b>(13): 2271–80. <a target=xrefwindow id=d68666e9734 href="http://www.ncbi.nlm.nih.gov/pubmed/25823825">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9738 href="http://dx.doi.org/10.1002/cncr.29364">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d68666e9747 class=n-a></a>Takai E, Totoki Y, Nakamura H, <i> et al.</i>: Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer. <i>Sci Rep.</i> 2015; <b>5</b>: 18425. <a target=xrefwindow id=d68666e9758 href="http://www.ncbi.nlm.nih.gov/pubmed/26669280">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9761 href="http://dx.doi.org/10.1038/srep18425">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9765 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4680882">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d68666e9774 class=n-a></a>Sausen M, Phallen J, Adleff V, <i> et al.</i>: Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. <i>Nat Commun.</i> 2015; <b>6</b>: 7686. <a target=xrefwindow id=d68666e9785 href="http://www.ncbi.nlm.nih.gov/pubmed/26154128">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9788 href="http://dx.doi.org/10.1038/ncomms8686">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9792 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4634573">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d68666e9802 class=n-a></a>Kulemann B, Pitman MB, Liss AS, <i> et al.</i>: Circulating tumor cells found in patients with localized and advanced pancreatic cancer. <i>Pancreas.</i> 2015; <b>44</b>(4): 547–50. <a target=xrefwindow id=d68666e9813 href="http://www.ncbi.nlm.nih.gov/pubmed/25822154">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9816 href="http://dx.doi.org/10.1097/MPA.0000000000000324">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d68666e9825 class=n-a></a>Zhang Y, Wang F, Ning N, <i> et al.</i>: Patterns of circulating tumor cells identified by CEP8, CK and CD45 in pancreatic cancer. <i>Int J Cancer.</i> 2015; <b>136</b>(5): 1228–33. <a target=xrefwindow id=d68666e9836 href="http://www.ncbi.nlm.nih.gov/pubmed/25042121">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9839 href="http://dx.doi.org/10.1002/ijc.29070">Publisher Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a name=d68666e9848 class=n-a></a>Wu J, Zhou Y, Zhang Y, <i> et al.</i>: Co-amplification at lower denaturation-temperature PCR combined with unlabled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in plasma-circulating DNA of pancreatic adenocarcinoma cases. <i>Asian Pac J Cancer Prev.</i> 2014; <b>15</b>(24): 10647–52. <a target=xrefwindow id=d68666e9859 href="http://www.ncbi.nlm.nih.gov/pubmed/25605154">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9862 href="http://dx.doi.org/10.7314/APJCP.2014.15.24.10647">Publisher Full Text </a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a name=d68666e9871 class=n-a></a>Bidard FC, Huguet F, Louvet C, <i> et al.</i>: Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. <i>Ann Oncol.</i> 2013; <b>24</b>(8): 2057–61. <a target=xrefwindow id=d68666e9882 href="http://www.ncbi.nlm.nih.gov/pubmed/23676420">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9885 href="http://dx.doi.org/10.1093/annonc/mdt176">Publisher Full Text </a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d68666e9894 class=n-a></a>Bobek V, Gurlich R, Eliasova P, <i> et al.</i>: Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation. <i>World J Gastroenterol.</i> 2014; <b>20</b>(45): 17163–70. <a target=xrefwindow id=d68666e9905 href="http://www.ncbi.nlm.nih.gov/pubmed/25493031">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9908 href="http://dx.doi.org/10.3748/wjg.v20.i45.17163">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9912 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4258587">Free Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718206842"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e9921 class=n-a></a>Rhim AD, Thege FI, Santana SM, <i> et al.</i>: Detection of circulating pancreas epithelial cells in patients with pancreatic cystic lesions. <i>Gastroenterology.</i> 2014; <b>146</b>(3): 647–51. <a target=xrefwindow id=d68666e9932 href="http://www.ncbi.nlm.nih.gov/pubmed/24333829">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9935 href="http://dx.doi.org/10.1053/j.gastro.2013.12.007">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4514438">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718206842">F1000 Recommendation</a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d68666e9953 class=n-a></a>Iwanicki-Caron I, Basile P, Toure E, <i> et al.</i>: Usefulness of circulating tumor cell detection in pancreatic adenocarcinoma diagnosis. <i>Am J Gastroenterol.</i> 2013; <b>108</b>(1): 152–5. <a target=xrefwindow id=d68666e9964 href="http://www.ncbi.nlm.nih.gov/pubmed/23287955">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9967 href="http://dx.doi.org/10.1038/ajg.2012.367">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d68666e9976 class=n-a></a>Sheng W, Ogunwobi OO, Chen T, <i> et al.</i>: Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. <i>Lab Chip.</i> 2014; <b>14</b>(1): 89–98. <a target=xrefwindow id=d68666e9987 href="http://www.ncbi.nlm.nih.gov/pubmed/24220648">PubMed Abstract </a> | <a target=xrefwindow id=d68666e9990 href="http://dx.doi.org/10.1039/c3lc51017d">Publisher Full Text </a> | <a target=xrefwindow id=d68666e9994 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3918168">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d68666e10003 class=n-a></a>Catenacci DV, Chapman CG, Xu P, <i> et al.</i>: Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. <i>Gastroenterology.</i> 2015; <b>149</b>(7): 1794–1803.e4. <a target=xrefwindow id=d68666e10014 href="http://www.ncbi.nlm.nih.gov/pubmed/26341722">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10017 href="http://dx.doi.org/10.1053/j.gastro.2015.08.050">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4985007">Free Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d68666e10030 class=n-a></a>Earl J, Garcia-Nieto S, Martinez-Avila JC, <i> et al.</i>: Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer. <i>BMC Cancer.</i> 2015; <b>15</b>: 797. <a target=xrefwindow id=d68666e10041 href="http://www.ncbi.nlm.nih.gov/pubmed/26498594">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10044 href="http://dx.doi.org/10.1186/s12885-015-1779-7">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10048 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4619983">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d68666e10057 class=n-a></a>Cauley CE, Pitman MB, Zhou J, <i> et al.</i>: Circulating Epithelial Cells in Patients with Pancreatic Lesions: Clinical and Pathologic Findings. <i>J Am Coll Surg.</i> 2015; <b>221</b>(3): 699–707. <a target=xrefwindow id=d68666e10068 href="http://www.ncbi.nlm.nih.gov/pubmed/26209458">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10071 href="http://dx.doi.org/10.1016/j.jamcollsurg.2015.05.014">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10075 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4546900">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d68666e10084 class=n-a></a>Kamande JW, Hupert ML, Witek MA, <i> et al.</i>: Modular microsystem for the isolation, enumeration, and phenotyping of circulating tumor cells in patients with pancreatic cancer. <i>Anal Chem.</i> 2013; <b>85</b>(19): 9092–100. <a target=xrefwindow id=d68666e10095 href="http://www.ncbi.nlm.nih.gov/pubmed/23947293">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10098 href="http://dx.doi.org/10.1021/ac401720k">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10102 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3832346">Free Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726862900"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10112 class=n-a></a>Takai E, Totoki Y, Nakamura H, <i> et al.</i>: Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer. <i>Adv Exp Med Biol.</i> 2016; <b>924</b>: 13–7. <a target=xrefwindow id=d68666e10123 href="http://www.ncbi.nlm.nih.gov/pubmed/27753011">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10126 href="http://dx.doi.org/10.1007/978-3-319-42044-8_3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726862900">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726410863"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10139 class=n-a></a>Hadano N, Murakami Y, Uemura K, <i> et al.</i>: Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer. <i>Br J Cancer.</i> 2016; <b>115</b>(1): 59–65. <a target=xrefwindow id=d68666e10150 href="http://www.ncbi.nlm.nih.gov/pubmed/27280632">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10153 href="http://dx.doi.org/10.1038/bjc.2016.175">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10157 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4931379">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726410863">F1000 Recommendation</a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d68666e10170 class=n-a></a>Zill OA, Greene C, Sebisanovic D, <i> et al.</i>: Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas. <i>Cancer Discov.</i> 2015; <b>5</b>(10): 1040–8. <a target=xrefwindow id=d68666e10181 href="http://www.ncbi.nlm.nih.gov/pubmed/26109333">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10184 href="http://dx.doi.org/10.1158/2159-8290.CD-15-0274">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10188 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4592417">Free Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d68666e10197 class=n-a></a>Kishimoto T, Eguchi H, Nagano H, <i> et al.</i>: Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer. <i>Cancer Sci.</i> 2013; <b>104</b>(12): 1626–31. <a target=xrefwindow id=d68666e10208 href="http://www.ncbi.nlm.nih.gov/pubmed/24118467">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10211 href="http://dx.doi.org/10.1111/cas.12300">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d68666e10220 class=n-a></a>Wang WS, Liu LX, Li GP, <i> et al.</i>: Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. <i>Cancer Prev Res (Phila).</i> 2013; <b>6</b>(4): 331–8. <a target=xrefwindow id=d68666e10231 href="http://www.ncbi.nlm.nih.gov/pubmed/23430754">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10234 href="http://dx.doi.org/10.1158/1940-6207.CAPR-12-0307">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d68666e10243 class=n-a></a>Kawaguchi T, Komatsu S, Ichikawa D, <i> et al.</i>: Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. <i>Br J Cancer.</i> 2013; <b>108</b>(2): 361–9. <a target=xrefwindow id=d68666e10254 href="http://www.ncbi.nlm.nih.gov/pubmed/23329235">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10257 href="http://dx.doi.org/10.1038/bjc.2012.546">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10261 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3566805">Free Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d68666e10271 class=n-a></a>Zhao C, Zhang J, Zhang S, <i> et al.</i>: Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma. <i>Oncol Rep.</i> 2013; <b>30</b>(1): 276–84. <a target=xrefwindow id=d68666e10282 href="http://www.ncbi.nlm.nih.gov/pubmed/23612862">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10285 href="http://dx.doi.org/10.3892/or.2013.2420">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d68666e10294 class=n-a></a>Carlsen AL, Joergensen MT, Knudsen S, <i> et al.</i>: Cell-free plasma microRNA in pancreatic ductal adenocarcinoma and disease controls. <i>Pancreas.</i> 2013; <b>42</b>(7): 1107–13. <a target=xrefwindow id=d68666e10305 href="http://www.ncbi.nlm.nih.gov/pubmed/24048453">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10308 href="http://dx.doi.org/10.1097/MPA.0b013e318296bb34">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d68666e10317 class=n-a></a>Que R, Ding G, Chen J, <i> et al.</i>: Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. <i>World J Surg Oncol.</i> 2013; <b>11</b>: 219. <a target=xrefwindow id=d68666e10328 href="http://www.ncbi.nlm.nih.gov/pubmed/24007214">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10331 href="http://dx.doi.org/10.1186/1477-7819-11-219">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10335 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3766671">Free Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718246797"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10344 class=n-a></a>Schultz NA, Dehlendorff C, Jensen BV, <i> et al.</i>: MicroRNA biomarkers in whole blood for detection of pancreatic cancer. <i>JAMA.</i> 2014; <b>311</b>(4): 392–404. <a target=xrefwindow id=d68666e10355 href="http://www.ncbi.nlm.nih.gov/pubmed/24449318">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10358 href="http://dx.doi.org/10.1001/jama.2013.284664">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718246797">F1000 Recommendation</a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d68666e10371 class=n-a></a>Silakit R, Loilome W, Yongvanit P, <i> et al.</i>: Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. <i>J Hepatobiliary Pancreat Sci.</i> 2014; <b>21</b>(12): 864–72. <a target=xrefwindow id=d68666e10382 href="http://www.ncbi.nlm.nih.gov/pubmed/25131257">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10385 href="http://dx.doi.org/10.1002/jhbp.145">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d68666e10394 class=n-a></a>Lin M, Chen W, Huang J, <i> et al.</i>: Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer. <i>Int J Clin Exp Med.</i> 2014; <b>7</b>(12): 5226–34. <a target=xrefwindow id=d68666e10405 href="http://www.ncbi.nlm.nih.gov/pubmed/25664025">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10408 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4307472">Free Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d68666e10418 class=n-a></a>Chen Q, Yang L, Xiao Y, <i> et al.</i>: Circulating microRNA-182 in plasma and its potential diagnostic and prognostic value for pancreatic cancer. <i>Med Oncol.</i> 2014; <b>31</b>(11): 225. <a target=xrefwindow id=d68666e10429 href="http://www.ncbi.nlm.nih.gov/pubmed/25326859">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10432 href="http://dx.doi.org/10.1007/s12032-014-0225-z">Publisher Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d68666e10441 class=n-a></a>Wang S, Yin J, Li T, <i> et al.</i>: Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma. <i>Oncol Rep.</i> 2015; <b>33</b>(2): 819–25. <a target=xrefwindow id=d68666e10452 href="http://www.ncbi.nlm.nih.gov/pubmed/25482320">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10455 href="http://dx.doi.org/10.3892/or.2014.3641">Publisher Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d68666e10464 class=n-a></a>Ganepola GA, Rutledge JR, Suman P, <i> et al.</i>: Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer. <i>World J Gastrointest Oncol.</i> 2014; <b>6</b>(1): 22–33. <a target=xrefwindow id=d68666e10475 href="http://www.ncbi.nlm.nih.gov/pubmed/24578785">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10478 href="http://dx.doi.org/10.4251/wjgo.v6.i1.22">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10482 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3936193">Free Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725823984"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10491 class=n-a></a>Voigtländer T, Gupta SK, Thum S, <i> et al.</i>: MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma. <i>PLoS One.</i> 2015; <b>10</b>(10): e0139305. <a target=xrefwindow id=d68666e10502 href="http://www.ncbi.nlm.nih.gov/pubmed/26431155">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10505 href="http://dx.doi.org/10.1371/journal.pone.0139305">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10509 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4591993">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725823984">F1000 Recommendation</a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d68666e10522 class=n-a></a>Abue M, Yokoyama M, Shibuya R, <i> et al.</i>: Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer. <i>Int J Oncol.</i> 2015; <b>46</b>(2): 539–47. <a target=xrefwindow id=d68666e10533 href="http://www.ncbi.nlm.nih.gov/pubmed/25384963">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10536 href="http://dx.doi.org/10.3892/ijo.2014.2743">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10540 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4277249">Free Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d68666e10549 class=n-a></a>Slater EP, Strauch K, Rospleszcz S, <i> et al.</i>: MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer. <i>Transl Oncol.</i> 2014; <b>7</b>(4): 464–71. <a target=xrefwindow id=d68666e10560 href="http://www.ncbi.nlm.nih.gov/pubmed/24956938">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10563 href="http://dx.doi.org/10.1016/j.tranon.2014.05.007">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10567 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4202799">Free Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a name=d68666e10577 class=n-a></a>Kojima M, Sudo H, Kawauchi J, <i> et al.</i>: MicroRNA markers for the diagnosis of pancreatic and biliary-tract cancers. <i>PLoS One.</i> 2015; <b>10</b>(2): e0118220. <a target=xrefwindow id=d68666e10588 href="http://www.ncbi.nlm.nih.gov/pubmed/25706130">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10591 href="http://dx.doi.org/10.1371/journal.pone.0118220">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10595 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4338196">Free Full Text </a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725591287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10604 class=n-a></a>Xu J, Cao Z, Liu W, <i> et al.</i>: Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls: A Multicenter Study. <i>Ann Surg.</i> 2016; <b>263</b>(6): 1173–9. <a target=xrefwindow id=d68666e10615 href="http://www.ncbi.nlm.nih.gov/pubmed/26114496">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10618 href="http://dx.doi.org/10.1097/SLA.0000000000001345">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725591287">F1000 Recommendation</a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a name=d68666e10631 class=n-a></a>Madhavan B, Yue S, Galli U, <i> et al.</i>: Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. <i>Int J Cancer.</i> 2015; <b>136</b>(11): 2616–27. <a target=xrefwindow id=d68666e10642 href="http://www.ncbi.nlm.nih.gov/pubmed/25388097">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10645 href="http://dx.doi.org/10.1002/ijc.29324">Publisher Full Text </a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a name=d68666e10654 class=n-a></a>Komatsu S, Ichikawa D, Miyamae M, <i> et al.</i>: Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma. <i>Expert Opin Biol Ther.</i> 2015; <b>15</b>(6): 773–85. <a target=xrefwindow id=d68666e10665 href="http://www.ncbi.nlm.nih.gov/pubmed/25819175">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10668 href="http://dx.doi.org/10.1517/14712598.2015.1029914">Publisher Full Text </a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725713796"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10677 class=n-a></a>Alemar B, Izetti P, Gregório C, <i> et al.</i>: miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma. <i>Pancreas.</i> 2016; <b>45</b>(1): 84–92. <a target=xrefwindow id=d68666e10688 href="http://www.ncbi.nlm.nih.gov/pubmed/26262588">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10691 href="http://dx.doi.org/10.1097/MPA.0000000000000383">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725713796">F1000 Recommendation</a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726767254"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10704 class=n-a></a>Wu X, Xia M, Chen D, <i> et al.</i>: Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma. <i>Tumour Biol.</i> 2016; <b>37</b>(11): 15019–29. <a target=xrefwindow id=d68666e10715 href="http://www.ncbi.nlm.nih.gov/pubmed/27658773">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10718 href="http://dx.doi.org/10.1007/s13277-016-5313-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726767254">F1000 Recommendation</a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726154733"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10732 class=n-a></a>Bernuzzi F, Marabita F, Lleo A, <i> et al.</i>: Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. <i>Clin Exp Immunol.</i> 2016; <b>185</b>(1): 61–71. <a target=xrefwindow id=d68666e10743 href="http://www.ncbi.nlm.nih.gov/pubmed/26864161">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10746 href="http://dx.doi.org/10.1111/cei.12776">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10750 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4908296">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726154733">F1000 Recommendation</a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a name=d68666e10763 class=n-a></a>Kim TH, Chang JH, Lee HJ, <i> et al.</i>: mRNA expression of CDH3, IGF2BP3, and BIRC5 in biliary brush cytology specimens is a useful adjunctive tool of cytology for the diagnosis of malignant biliary stricture. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(27): e4132. <a target=xrefwindow id=d68666e10774 href="http://www.ncbi.nlm.nih.gov/pubmed/27399126">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10777 href="http://dx.doi.org/10.1097/MD.0000000000004132">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10781 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5058855">Free Full Text </a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727649514"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10790 class=n-a></a>Duell EJ, Lujan-Barroso L, Sala N, <i> et al.</i>: Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study. <i>Int J Cancer.</i> 2017; <b>141</b>(5): 905–15. <a target=xrefwindow id=d68666e10801 href="http://www.ncbi.nlm.nih.gov/pubmed/28542740">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10804 href="http://dx.doi.org/10.1002/ijc.30790">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10808 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5536971">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727649514">F1000 Recommendation</a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727133721"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d68666e10821 class=n-a></a>Branchi V, Schaefer P, Semaan A, <i> et al.</i>: Promoter hypermethylation of <i>SHOX2</i> and <i>SEPT9</i> is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract. <i>Clin Epigenetics.</i> 2016; <b>8</b>: 133. <a target=xrefwindow id=d68666e10839 href="http://www.ncbi.nlm.nih.gov/pubmed/27999621">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10842 href="http://dx.doi.org/10.1186/s13148-016-0299-x">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10845 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5153824">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727133721">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a name=d68666e10858 class=n-a></a>Dhar DK, Olde Damink SW, Brindley JH, <i> et al.</i>: Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer. <i>Cancer.</i> 2013; <b>119</b>(3): 575–85. <a target=xrefwindow id=d68666e10869 href="http://www.ncbi.nlm.nih.gov/pubmed/22864959">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10872 href="http://dx.doi.org/10.1002/cncr.27611">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3492546">Free Full Text </a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d68666e10885 class=n-a></a>Navaneethan U, Lourdusamy V, Poptic E, <i> et al.</i>: Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures. <i>Dig Dis Sci.</i> 2015; <b>60</b>(4): 903–9. <a target=xrefwindow id=d68666e10896 href="http://www.ncbi.nlm.nih.gov/pubmed/25344422">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10899 href="http://dx.doi.org/10.1007/s10620-014-3397-7">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a name=d68666e10909 class=n-a></a>Keane MG, Huggett MT, Chapman MH, <i> et al.</i>: Diagnosis of pancreaticobiliary malignancy by detection of minichromosome maintenance protein 5 in biliary brush cytology. <i>Br J Cancer.</i> 2017; <b>116</b>(3): 349–55. <a target=xrefwindow id=d68666e10920 href="http://www.ncbi.nlm.nih.gov/pubmed/28081547">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10923 href="http://dx.doi.org/10.1038/bjc.2016.447">Publisher Full Text </a> | <a target=xrefwindow id=d68666e10927 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5294492">Free Full Text </a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d68666e10936 class=n-a></a>Danese E, Ruzzenente O, Ruzzenente A, <i> et al.</i>: Assessment of bile and serum mucin5AC in cholangiocarcinoma: diagnostic performance and biologic significance. <i>Surgery.</i> 2014; <b>156</b>(5): 1218–24. <a target=xrefwindow id=d68666e10947 href="http://www.ncbi.nlm.nih.gov/pubmed/25151557">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10950 href="http://dx.doi.org/10.1016/j.surg.2014.05.006">Publisher Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d68666e10959 class=n-a></a>Farina A, Dumonceau JM, Antinori P, <i> et al.</i>: Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses. <i>Biochim Biophys Acta.</i> 2014; <b>1844</b>(5): 1018–25. <a target=xrefwindow id=d68666e10970 href="http://www.ncbi.nlm.nih.gov/pubmed/23806607">PubMed Abstract </a> | <a target=xrefwindow id=d68666e10973 href="http://dx.doi.org/10.1016/j.bbapap.2013.06.010">Publisher Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d68666e10982 class=n-a></a>Budzynska A, Nowakowska-Dulawa E, Marek T, <i> et al.</i>: Differentiation of pancreatobiliary cancer from benign biliary strictures using neutrophil gelatinase-associated lipocalin. <i>J Physiol Pharmacol.</i> 2013; <b>64</b>(1): 109–14. <a target=xrefwindow id=d68666e10993 href="http://www.ncbi.nlm.nih.gov/pubmed/23568978">PubMed Abstract </a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a name=d68666e11002 class=n-a></a>Roy R, Zurakowski D, Wischhusen J, <i> et al.</i>: Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. <i>Br J Cancer.</i> 2014; <b>111</b>(9): 1772–9. <a target=xrefwindow id=d68666e11013 href="http://www.ncbi.nlm.nih.gov/pubmed/25137018">PubMed Abstract </a> | <a target=xrefwindow id=d68666e11016 href="http://dx.doi.org/10.1038/bjc.2014.462">Publisher Full Text </a> | <a target=xrefwindow id=d68666e11020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4453724">Free Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 05 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1643/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1643/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Institute of Liver Studies, King's College Hospital, London, UK<br/> <sup>2</sup> UCL Institute for Liver and Digestive Health, Royal Free Campus, London, UK<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1643/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 05 Sep 2017, 6:1643 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11371.1">https://doi.org/10.12688/f1000research.11371.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Keane MG <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12275 data-id=11371 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11371.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1643/v1/pdf?article_uuid=082c9d35-7976-4f33-8cea-4059ddc78cd8" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11371.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Keane MG, Shah A, Pereira SP and Joshi D. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1643 (<a href="https://doi.org/10.12688/f1000research.11371.1" target=_blank>https://doi.org/10.12688/f1000research.11371.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11371 id=mobile-track-article-signin-11371 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11371?target=/articles/6-1643/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12275 /> <input name=articleId type=hidden value=11371 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Pietro Fusaroli</strong>, Gastroenterology Unit, Department of Medical and Surgical Science, Hospital of Imola, University of Bologna, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter Vilmann</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Pia Helene Klausen</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Vangelis Kalaitzakis</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 05 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1643/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1643/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25505-25396></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25506-25395></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1643/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>05 Sep 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Pietro Fusaroli</strong>, Gastroenterology Unit, Department of Medical and Surgical Science, Hospital of Imola, University of Bologna, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter Vilmann</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Pia Helene Klausen</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Vangelis Kalaitzakis</strong>, Gastro Unit, Department of Surgery, Herlev Hospital, University of Copenhagen, Denmark </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1643/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1643/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Novel biomarkers and endoscopic techniques...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1643/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1643/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1643/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Keane MG et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1643/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1643",
            templates : {
                twitter : "Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary.... Keane MG et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1643/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11371/12275")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12275");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "25395": 0,
                           "25396": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "17d5f3ac-a57b-46f5-bebb-cb2d0166abf2";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1643.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1643.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1643.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1643.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1643.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>